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Abstract 
 
Aquatic and non-aquatic ecosystems differ with regards to metabolism as well as exposure and uptake routes. Current international and 
European regulatory criteria for Persistence, Bioaccumulation, and Toxicity (PBT) assessment of chemical substances are mainly based on 
toxicity and bioaccumulation data in aquatic species. In the literature, there is evidence that several persistent organic chemicals, which 
are not classified as bioaccumulative and/or toxic in aquatic organisms according to existing criteria, can biomagnify in non-aquatic food 
chains up to the top predators (including humans) and exert their toxicity. Therefore, the regulatory frameworks may fail to identify a 
number of substances that are bioaccumulative and/or toxic in non-aquatic organisms and related food chains (exposed through soil and 
food), but not in aquatic species. Based on these considerations, two reports were prepared on available criteria for non-aquatic 
organisms within PBT/vPvB frameworks: one on bioaccumulation assessment (Part I) and one on toxicity assessment (Part II). Specifically, 
the present document illustrates and discusses the outcomes of a regulatory and literature review on available criteria for 
bioaccumulation assessment in non-aquatic organisms at international and European level (Part I). This report could be used to support 
an eventual revision of guidance documents, e.g. for REACH (EU Regulation 1907/2006), as well as to promote the harmonisation of 
regulatory criteria for PBT/vPvB assessment. 
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Preface 
This report has been prepared in the frame of an Administrative Arrangement between the 
Directorate-General Environment (DG ENV) and the Joint Research Centre (JRC), Institute for Health 
and Consumer Protection (IHCP) on 'Scientific and technical support to safety assessment of 
chemicals'. One of the requests of DG ENV was to carry out a review of available criteria for 
bioaccumulation and toxicity assessment in non-aquatic organisms within current regulatory 
Persistent Bioaccumulative Toxic (PBT) and/or very Persistent very Bioaccumulative (vPvB) 
assessment frameworks. 
Based on this request two reports were prepared on available criteria for non-aquatic organisms 
within PBT/vPvB frameworks: the present one on bioaccumulation assessment (Part I) and one on 
toxicity assessment (Part II) (Hartmann et al. 2014). An intermediate version of this report on 
bioaccumulation assessment was circulated to participants of the PBT Expert Group of the European 
Chemicals Agency (ECHA). Thereafter, the report has been amended, taking into consideration the 
comments and suggestions of the ECHA PBT Expert Group. 
We would like to thank the experts of the ECHA PBT Expert Group and the colleagues from DG ENV, 
ECHA and the JRC for their useful comments. 
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Executive Summary 
Current international and European regulatory criteria for bioaccumulation assessment under 
frameworks for identification of substances with Persistent Bioaccumulative Toxic (PBT) and/or very 
Persistent very Bioaccumulative (vPvB) properties are mainly focused on the aquatic compartment 
and use the Bioaccumulation Factor (BAF) or Bioconcentration Factor (BCF) in aquatic species and/or 
the octanol-water partitioning coefficient (Kow) as metrics.  
In the literature, there is evidence that several persistent organic chemicals, which are not 
considered as bioaccumulative in aquatic organisms according to existing criteria, can biomagnify in 
non-aquatic food chains up to the top predators, including humans. This occurs as non-aquatic 
organisms differ from aquatic ones in terms such as uptake and elimination mechanisms, diet, energy 
requirements, and feeding rates. Therefore, there is a risk that these regulatory frameworks for 
PBT/vPvB assessment neglect a group of substances that are bioaccumulative in the non-aquatic 
compartment. 
Based on these considerations, the Joint Research Centre (JRC), Institute for Health and Consumer 
Protection (IHCP), was asked by the Directorate-General Environment (DG ENV) to prepare a 
regulatory and literature review on available criteria for bioaccumulation and toxicity assessment in 
non-aquatic organisms to support the revision process of the ECHA Guidance on information 
requirements and chemical safety assessment. Chapter R.11: PBT assessment for implementation of 
the European chemicals legislation (REACH Regulation 1907/2006), as well as to promote the 
harmonisation of regulatory criteria for PBT/vPvB assessment at European level. 
The literature review points out that there is consensus in the scientific community on the combined 
use of criteria based on predictive physico-chemical parameters such as Koa (octanol-air partitioning 
coefficient) > 5 or 6 and Kow > 2, which are easy to calculate and implement, and should therefore be 
considered within existing PBT/vPvB assessment frameworks, especially for screening purposes. 
In a more detailed bioaccumulation assessment that is usually performed at higher tier, there is 
general agreement in the scientific community that all available bioaccumulation metrics need to be 
considered as complementary lines of evidence and evaluated in a weight of evidence approach (in 
line with the principles outlined in the REACH Annex XIII published in 2011). Specifically, it is 
recommended that both bioconcentration and biomagnification are investigated by means of 
multiple laboratory and field metrics and that aquatic and non-aquatic compartments are separately 
addressed. Specifically, BSAF (Biota/Soil Accumulation Factor) and BCF values in soil organisms such 
as earthworms seem to represent good indicators for the bioaccumulation potential at the base of 
non-aquatic food chains, despite several technical limitations. As food is the main exposure route for 
non-aquatic organisms and it is demonstrated that biomagnification can be higher in non-aquatic 
food webs compared to aquatic ones, field-based BMF (Biomagnification Factor) and TMF (Trophic 
Magnification Factor) values determined for non-aquatic food webs could be considered. 
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Furthermore, the elimination half-life has been proposed recently in the literature as an alternative 
bioaccumulation metric. 
In conclusion, the scientific community has suggested several metrics to overcome the lack of 
consideration of the non-aquatic compartment in the regulatory PBT/vPvB assessment of substances. 
However, research efforts are still needed to improve the scientific understanding of the proposed 
metrics and define cut-off values. Moreover, the impact that the introduction of non-aquatic criteria 
in a regulatory context may have needs to be analysed in depth. 
It is important to note that suggestions provided in this document should not be considered as an 
attempt to define a regulatory strategy on how to screen and/or assess substances based on their 
bioaccumulation potential in non-aquatic organisms nor to evaluate the impact of such a strategy on 
e.g. the REACH implementation process. Further elaboration is needed to integrate the knowledge 
summarised in the present document into the current regulatory framework. This could be the work 
for a dedicated expert group. 
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1 Background and scope 
Current international and European regulatory criteria on bioaccumulation assessment are mainly 
based on the use of the Bioaccumulation Factor (BAF) or Bioconcentration (BCF) in aquatic species 
and the octanol-water partitioning coefficient (Kow) (see Annex I, Glossary). BCF and BAF values are 
generally determined for aquatic organisms. BCF values are obtained under laboratory-controlled 
conditions and do not take the exposure route through the diet into account (Gobas et al. 2009; 
Ehrlich et al. 2011; Goss et al. 2013). BAF values are generally preferred as they are more ecologically 
relevant (field experiments, steady-state conditions, all exposure routes) than BCF values for the 
same species; however, BAF values are largely variable due to site-specific environmental conditions 
affecting their determination and less available than BCF values (Arnot and Gobas 2006; Weisbroad 
et al. 2009; Costanza et al. 2012). Kow is a measure of the equilibrium partitioning of organic 
compounds between water and octanol, which is considered representative for the lipid in biota, and 
therefore only apply to estimation of aquatic bioaccumulation. 
Nonetheless, there is evidence in the literature that several persistent organic chemicals, which are 
not classified as bioaccumulative in aquatic organisms according to Kow/BCF/BAF-based criteria, can 
biomagnify in non-aquatic food chains up to the top predators, including humans (e.g. Kelly and 
Gobas 2001; Kelly and Gobas 2003; Kelly et al. 2007; Tonnelier et al. 2011). There is therefore a risk 
that regulatory frameworks may neglect a group of substances, which are bioaccumulative in non-
aquatic organisms and related food chains. 
A number of OECD Test Guidelines (TGs) are available to generate bioaccumulation data that can be 
used in a regulatory context. In 2012, the OECD TG 305 on Bioaccumulation in Fish: Aqueous and 
Dietary Exposure has been adopted (OECD 2012). This Test Guideline was updated in order to 
incorporate dietary exposure in fish and therefore enable determination of bioaccumulation 
potential of very poorly water soluble substances. The OECD TG 315 on Bioaccumulation in Sediment-
dwelling Benthic Oligochaetes is also available (OECD 2008). In 2010, OECD recognised that 
extrapolation from aquatic bioaccumulation data to non-aquatic organisms is difficult, if not possible, 
and developed the OECD TG 317 on Bioaccumulation in Terrestrial Oligochaetes (OECD 2010), which 
may help with obtaining an indication of the bioaccumulation potential for low trophic levels of the 
non-aquatic food chains.  
As far as the European REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) 
Regulation 1907/2006 (EC 2006) is concerned, the criteria for PBT (Persistent Bioaccumulative Toxic) 
and vPvB (very Persistent very Bioaccumulative) assessment presented in Annex XIII to the legal text 
was revised and published as European Regulation 253/2011 (EC 2011). The guidance document for 
the implementation of REACH of the European Chemicals Agency (ECHA) named Guidance on 
information requirements and chemical safety assessment. Chapter R.11: PBT assessment (ECHA 
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2012a) is currently under review and its publication is expected soon3. A major change in the Annex 
XIII concerns the explicit requirement for a weight of evidence approach considering all available 
relevant information to derive a conclusion on P, B and T properties. Moreover, criteria for 
bioaccumulation assessment now specifically ask for considering bioaccumulation in terrestrial 
species, data from human body fluids or tissues and biomagnification in the food chain in addition to 
bioconcentration and/or bioaccumulation in aquatic species. However, threshold values are given for 
BCF and BAF criteria in aquatic species only. 
The Joint Research Centre's Institute for Health and Consumer Protection (JRC-IHCP) was asked by 
the Directorate-General on Environment to support the review process of the ECHA Guidance on 
information requirements and chemical safety assessment. Chapter R.11: PBT assessment as well as 
to promote the harmonisation of regulatory criteria for PBT assessment at European level by 
preparing a state-of-the-art report on bioaccumulation and toxicity assessment in non-aquatic 
organisms. In this context, the present document is aimed to: i) review the legislative status of 
bioaccumulation assessment in different international and European regulatory frameworks and ii) 
present and discuss available criteria and approaches for screening and assessment of 
bioaccumulation potential of chemicals. The ultimate goal of the document is to provide initial 
suggestions on possible criteria that enable the identification of substances that may accumulate and 
biomagnify in non-aquatic environments in addition to the aquatic ones. Suggestions provided in this 
document should not be considered as an attempt to define a regulatory strategy on how to screen 
and/or assess substances based on their bioaccumulation potential in non-aquatic organisms nor to 
evaluate the impact of such a strategy on e.g. the REACH implementation process. Further 
elaboration would be needed to integrate the knowledge summarised in the present document into 
the current regulatory framework. This could be the work for a dedicated expert group. 
An intermediate version of this document was made available as background document to the ECHA 
PBT Expert Group as well as to the PEG (Partner Expert Group) established for reviewing the ECHA 
Guidance on information requirements and chemical safety assessment. Chapter R.11: PBT 
assessment. Comments to the document were received by several experts from ECHA, Member State 
Competent Authorities as well as industry and were addressed accordingly.  
In summary, Section 2 briefly describes the current use of criteria for bioaccumulation assessment in 
international and European regulations while their limitations are discussed in Section 3. Section 4 
aims at illustrating and discussing a series of evidences on bioaccumulation in non-aquatic organisms 
which have been reported in the literature. Based on that, Section 5 focuses on possible criteria and 
approaches for the identification of bioaccumulative substances in non-aquatic organisms and 
discusses advantages and disadvantages of several literature proposals. In Section 6, on-going 
                                                            
3 Link to the ECHA website where last draft is available: http://echa.europa.eu/support/guidance/consultation-
procedure/ongoing-reach  
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initiatives that could provide more information and tools on bioaccumulation in non-aquatic 
environments in the near future are briefly illustrated. Finally, Section 7 explains the main 
conclusions. In order to ensure a common understanding of the issues tackled in the present 
document, Annex I contains a glossary of the key terms. 
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2 International and European regulatory criteria for bioaccumulation 
assessment 
Official criteria that are used for bioaccumulation assessment of substances in several international 
and European regulatory frameworks are summarised in Table 1.  
Bioaccumulation assessment is required to i) identify Persistent, Bioaccumulative and Toxic (PBT) 
and/or very Persistent very Bioaccumulative (vPvB) substances or Persistent Organic Pollutants 
(POPs), which correspond to PBT/vPvB substances that are also characterised by long-range 
transport potential, or to ii) classify the hazard to the environment of the substances in a more 
generic way. The assessment is generally based on the use of the Bioaccumulation Factor (BAF) or 
Bioconcentration Factor (BCF) in aquatic species or, in the absence of such experimental data, the 
logarithmic octanol/water partitioning coefficient (log Kow) (see Annex I, Glossary). Cut-off values for 
BAF/BCF in aquatic species and log Kow are usually recommended. Some regulatory frameworks 
provide qualitative criteria for bioaccumulation assessment, which give the possibility of using data 
for non-aquatic organisms in a few cases as discussed below.  
Under international regulatory frameworks for POPs identification such as the United Nations 
Economic Commission for Europe (UN ECE) POP Protocol (UN ECE 1996; 1998) and United Nations 
Environment Programme (UNEP) Stockholm Convention (UNEP 2001; 2009)4, a substance is 
classified as 'bioaccumulative' if the value of the BCF or BAF in aquatic species is greater than 5000 
L/Kg or, in the absence of such experimental data, if the log Kow is greater than 5.  
Similar numerical criteria are applied for PBT substances identification in the Canadian Environment 
Protection Act (CEPA) (Government of Canada 1999; 2004) (see Table 1). Under the Convention for 
the Protection of the marine Environment of the North-East Atlantic (OSPAR Convention), more 
stringent cut-off values (i.e. one order of magnitude lower for both BCF and log Kow) were chosen for 
determining whether a substance has the 'liability to bioaccumulate' (OSPAR 1992; 2010) (see Table 
1), meaning that more substances will fulfil the criteria of being liable to bioaccumulate. This is 
probably due to the fact that chemicals of concern under OSPAR are used off-shore and directly 
released into the environment (as suggested by Moermond et al. (2011)).  
                                                            
4 In 2001, twelve POPs (called 'the dirty dozen' and including pesticides, industrial chemicals and by-products) were listed 
under Annex A (elimination), B (restriction) or C (unintentional production) of the Stockholm Convention: i.e. aldrin, 
chlordane, DDT, dieldrin, endrin, heptachlor, hexachlorobenzene (HCB), mirex, toxaphene, polychlorinated biphenyls 
(PCBs), polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans (PCDDs/PCDFs). In 2009, nine new POPs 
were added to the initial list: i.e. chlordecone, alpha hexachlorocyclohexane (α-HCH), beta hexachlorocyclohexane (β-
HCH), lindane, pentachlorobenzene, hexabromodiphenyl ether and heptabromodiphenyl ether, pentachlorobenzene, 
perfluorooctane sulfonic acid (PFOS), its salts and perfluorooctane sulfonyl fluoride, tetrabromodiphenyl ether and 
pentabromodiphenyl ether. In 2011, Annex A was amended to include technical endosulfan and its related isomers.  
(Source: http://chm.pops.int/Convention/ThePOPs/TheNewPOPs/tabid/2511/Default.aspx) 
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In spite of that, not only quantitative criteria based on BAF/BCF or log Kow but also qualitative criteria 
can be used for bioaccumulation assessment in some frameworks. These criteria give some flexibility 
to the classification schemes and allow for consideration of additional evidences such as high 
(eco)toxicity and monitoring data. Under the UN ECE POP Protocol, it is explicitly stated that if the 
bioaccumulation potential is significantly lower than the numerical criteria, other factors such as high 
toxicity of the substance that may raise concern within the scope of the protocol can be considered 
(UN ECE 1998). Under the UNEP Stockholm Convention (UNEP 2001; 2009), two qualitative criteria 
are given: i) information suggesting other reasons of concern such as evidence of bioaccumulation in 
other species than the aquatic ones, high toxicity and high ecotoxicity; and ii) monitoring data in 
biota. In this framework, it is therefore explicitly required to consider bioaccumulation in other 
species than the aquatic ones as additional evidence. In 2007, Kitano prepared a Discussion Paper on 
Bioaccumulation Evaluation for the Third Meeting of the POPs Review Committee where he pointed 
out the role of the qualitative criteria in the screening of bioaccumulation properties for substances 
that do not exceed the cut-off values defined for BCF/BAF and/or log Kow. In this case, Kitano 
suggested that several pieces of information such as BCF values, half-life, biomagnification, 
toxicity/(eco)toxicity, monitoring in biota and human body as well as exposure in development stages 
should be considered in a weight of evidence approach to derive a conclusion on the 
bioaccumulation properties of a substance (Kitano 2007). In the Stockholm Convention it is also 
stated that the criteria for POPs identification are meant for screening and should not be applied in a 
rigid way but in an integrative and balanced approach considering all available information.  
Under the European REACH Regulation 1907/2006 (EC 2006), a framework for PBT and vPvB 
assessment including both quantitative and qualitative criteria is provided in Annex XIII (EC 2011)5. 
REACH Annex XIII explicitly requires that all available information in registration dossiers and open 
literature shall be considered in a weight of evidence approach to draw a conclusion on the P, B and 
T properties of a substance. In case only few data is available, a reduced dataset can be used to 
screen for bioaccumulation properties and eventually conclude that the substance does not have a 
bioaccumulation potential. The screening dataset includes: i) the log Kow; and ii) other suitable and 
reliable information. If, based on screening information, the substance shows bioaccumulation 
properties, additional data needs to be considered and eventually generated before deriving a 
conclusion. The dataset that is required for a proper bioaccumulation assessment includes: i) 
bioaccumulation in aquatic species; ii) other information on the bioaccumulation potential such as 
bioaccumulation study in terrestrial species, human body fluids or tissues, detected high levels in 
                                                            
5 In the frame of REACH, the assessment of PBT and/or vPvB profiles is necessary to identify Substances of Very High 
Concern (SVHC) to be included in the REACH Candidates List for Authorisation. So far, 16 out of 73 chemicals on the list 
have been included due to their PBT and/or vPvB properties: i.e. antracene and several types of antracene oil, musk 
xylene, pitch coal tar, trybutiltin oxide (TBTO), alkanes C10-13 chloro, hexabromocyclododecane (HBCDD), 
decabromodiphenyl ether (DecaBDE), and four perfluorocarboxylic acids (i.e. henicosafluoroundecanoic acid, 
heptacosafluorotetradecanoic acid, tricosafluorododecanoic acid, pentacosafluorotridecanoic acid). (Source: 
http://echa.europa.eu/web/guest/candidate-list-table). 
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biota, chronic toxicity study on animals, toxicokinetic behaviour; and iii) information on the ability of 
the substance to biomagnify possibly based on the Biomagnification Factor (BMF) or Trophic 
Magnification Factor (TMF) (see Annex I, Glossary). These requirements point out that a 
comprehensive assessment is necessary and bioaccumulation in other species, in addition to the 
aquatic ones, as well as magnification through the food chains need to be investigated before 
drawing a conclusion on the bioaccumulation potential of a substance. To this end, REACH explicitly 
requires a weight of evidence approach. The numerical criteria given in Annex XIII concern 
bioaccumulation in aquatic species only and correspond to two cut-off values: if the BCF/BAF value is 
higher than 2000 L/Kg, then the substance is classified as 'bioaccumulative' (B); if the value is higher 
than 5000 L/Kg, then the substance is classified as 'very bioaccumulative' (vB) (see Table 1). No 
threshold values are given for the remaining criteria mentioned in Annex XIII. ECHA developed a 
Guidance Document for implementation of PBT/vPvB assessment under REACH (ECHA 2012a) where 
additional numerical criteria are suggested. For example, it is stated that log Kow lower than or equal 
to 4.5 can be used as screening criterion for classification of the substance as 'not bioaccumulative' 
(not B, not vB). Moreover, in the Guidance Document values of BMF higher than 1 are considered as 
convincing evidence that the substance can biomagnify in food chains. Additional indicators are 
proposed in the Guidance Document, provided that they are used in combination with other 
information. For example: the maximum molecular length of a substance higher than 4.3 nm may 
indicate a low bioaccumulation potential; a molecular weight higher than 1100 g/mol or in the range 
of 700-1100 g/mol is an indicator that the aquatic BCF of the substance is lower than 2000 L/Kg (not 
B) or lower than 5000 L/Kg (not vB), respectively; no uptake by mammals may suggest that the 
substance does not pass through the gills membranes and consequently does not bioaccumulate in 
fish. However, the Guidance Document does not give any specific indication on how the available 
data and indicators could be assessed and integrated in a weight of evidence approach (as also 
pointed out by Solomon et al. (2013)). It has to be underlined that the Guidance Document is 
currently under review in order to align it with the current Annex XIII provisions; consequently, the 
abovementioned additional indicators and criteria may undergo modifications and more information 
on how to apply the weight of evidence approach may be provided. The consultation procedure of 
the updated Guidance Document is ongoing and draft versions are downloadable from the ECHA 
website6. Publication is expected soon. 
As pointed out by Moermond et al. (2011), the BCF/BAF threshold value used under UNEP and UN 
ECE international frameworks equals the vB criterion in REACH, which means REACH is more 
protective as it also provides a lower threshold value for the B criterion. The US Toxic Substances 
Control Act (TSCA) (US EPA 1998; 2002) distinguishes between substances that show a 'tendency to 
accumulate in organisms' (BCF/BAF: 1000-5000 L/Kg) and those ones with 'properties consistent with 
substances widely acknowledged to be bioaccumulative' (BCF/BAF > 5000 L/Kg). In this case the 
highest cut-off value is the same as the vB criterion under REACH while the lowest cut-off value used 
                                                            
6 http://echa.europa.eu/support/guidance/consultation-procedure/ongoing-reach  
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in the US is more stringent than the B criterion applied in REACH (i.e. BCF/BAF: 1000-5000 L/Kg vs 
BCF/BAF > 2000 L/Kg). 
The regulatory requirement of considering all available relevant information in a weight of evidence 
approach in the current REACH Annex XIII has introduced dissimilarities in the PBT assessment 
frameworks at European level (Moermond et al. 2011). For example, whereas the Biocidal Products 
Regulation (BPR) 528/2012 (EC 2012) explicitly refers to REACH Annex XIII and its provisions, the 
Plant Protection Products (PPPs) Regulation 1107/2009 (EC 2009) does not require a weight of 
evidence approach but relies on numerical criteria for bioconcentration in aquatic organisms only 
(see Table 1). As concluded by Moermond et al. (2011) and recalled in Solomon et al. (2013) as well 
as in Rauert et al. (2014), these differences in criteria (in terms of both threshold values and 
approach) create a challenge to harmonise the PBT/vPvB assessment of substances at European 
level. Solomon et al. (2013) advocates the use of a formal, quantitative and transparent process of 
weight of evidence in categorisation of pesticides under the PPPs Regulation 1107/2009. In addition, 
the Authors recognise the need of developing criteria for bioaccumulation and toxicity in non-aquatic 
organisms, which could be applied when pesticides exhibit persistence in soil (not aquatic) 
compartment. Similarly, Rauert et al. (2014) recommend that all available information is considered 
in a weight of evidence approach under all regulatory frameworks. 
Under existing regulatory frameworks for hazard classification and labelling, such as the Globally 
Harmonised System (GHS) of Classification and Labelling of chemicals (UN 2013) and the European 
Regulation on 'Classification, Labelling and Packaging (CLP) of substances and mixtures' (EC 2008), 
the 'potential of a substance to bioconcentrate' in aquatic organisms (along with aquatic toxicity data 
and degradability) is considered in the procedure for classification of a substance as hazardous for 
the environment. In these frameworks, the recommended cut-off values for log Kow and BCF in 
aquatic species are one order of magnitude more stringent than the ones used for bioaccumulation 
assessment under POP/PBT/vPvB frameworks, meaning that more substances will fulfil the criteria of 
having potential to bioaccumulate. 
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Table 1. Overview of quantitative and qualitative criteria for bioaccumulation assessment in different 
international and European regulatory frameworks. POP = Persistent Organic Pollutant; PBT = Persistent 
Bioaccumulative Toxic; vPvB = very Persistent very Bioaccumulative; BCF = Bioconcentration Factor; BAF = 
Bioaccumulation Factor; Kow = octanol-water partitioning coefficient; BMF = Biomagnification Factor; TMF = 
Trophic Magnification Factor. 
Assessment 
Framework 
Regulation Bioaccumulation Criteria Reference 
POPs identification UN ECE POP 
Protocol 
BCF or BAF (aquatic) > 5000 
Or: 
Log Kow > 5 
Alternatively, if the bioaccumulation 
potential is significantly lower than above, 
other factors such as high toxicity of the 
substance, that make it concern within the 
scope of the protocol. 
UN ECE 1996; 1998 
POPs identification UNEP Stockholm 
Convention 
Annex D 
Information 
requirements and 
screening criteria 
 
 
 
 
 
Article 8 (3) 
BCF or BAF (aquatic) > 5000 
Or: 
Log Kow > 5 
Or: 
Other reasons of concern (e.g. high 
bioaccumulation in other species, high 
toxicity, ecotoxicity) 
Or: 
Monitoring data in biota 
'The Committee shall examine the proposal 
and apply the screening criteria specified in 
Annex D in a flexible and transparent way, 
taking all information provided into 
account in an integrative and balanced 
manner.' 
UNEP 2001; 2009 
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Table 1. (cont.) 
Assessment 
Framework 
Regulation Bioaccumulation Criteria Reference 
POPs identification EU Plant Protection 
Product Regulation 
(1107/2009) 
BCF or BAF (aquatic) > 5000 
Or: 
Log Kow > 5 
Or: 
Other reasons of concern (e.g. high 
bioaccumulation in other non-target 
species, high toxicity or ecotoxicity) 
EC 2009 
PBT substances 
identification 
OSPAR Convention Log Kow ≥ 4 
Or: 
BCF (aquatic) ≥ 500 
OSPAR 1992; 2010 
PBT substances 
identification 
Canadian 
Environmental 
Protection Act 
(CEPA) 
BAF (aquatic) ≥ 5000 
Or: 
BCF (aquatic) ≥ 5000 
Or: 
Log Kow ≥ 5 
Government of Canada 
1999; 2004 
PBT/vPvB substances 
identification 
US Toxic Substances 
Control Act (TSCA) 
Tendency to accumulation in organisms:  
BCF or BAF (aquatic): 1000-5000 
Properties consistent with substances 
widely acknowledged  to be 
bioaccumulative (ban criteria):  
BCF or BAF (aquatic) ≥ 5000 
US EPA 1998; 2002 
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Table 1. (cont.) 
Assessment 
Framework 
Regulation Bioaccumulation Criteria Reference 
PBT/vPvB substances 
identification 
Australian National 
Industrial Chemicals 
Notification and 
Assessment Scheme 
(NICNAS) 
B: BCF or BAF (aquatic) > 2000 
Or: 
Log Kow > 4.2 
Substances with vB properties are defined 
and identified according to criteria 
provided by Stockholm Convention on 
POPs 
Australian Government 
2013 
EPHC 2009 
PBT/vPvB substances 
identification 
EU REACH 
Regulation 
(1907/2006) Annex 
XIII 
Screening based on weight of evidence: 
Log Kow 
And: 
Other suitable and reliable information  
 
Assessment based on weight of evidence: 
Bioaccumulation in aquatic species: 
B: BCF or BAF (aquatic) > 2000 
vB: BCF or BAF (aquatic) > 5000 
And: 
Other information on bioaccumulation 
potential (e.g. bioaccumulation study in 
terrestrial species, human body fluids or 
tissues, detected high levels in biota, 
chronic toxicity study on animals, 
toxicokinetic behaviour) 
And: 
Information on the ability to biomagnify 
(where possible: BMF or TMF) 
EC 2006; 2011 
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Table 1. (cont.) 
Assessment 
Framework 
Regulation Bioaccumulation Criteria Reference 
PBT/vPvB substances 
identification 
EU Plant Protection 
Product Regulation 
(1107/2009) 
B: BCF (aquatic) > 2000 
vB: BCF (aquatic) > 5000 
EC 2009 
PBT/vPvB substances 
identification 
EU Biocidal 
Products Regulation 
(528/2012) 
In accordance with Annex XIII to REACH 
Regulation 1907/2006 
EC 2012 
Hazard classification 
and labelling 
UN Globally 
Harmonised System 
(GHS) 
Log Kow ≥ 4 
Or: 
BCF (aquatic) ≥ 500 
UN, 2013 
Hazard classification 
and labelling 
EU CLP Regulation 
(1272/2008) 
Log Kow ≥ 4 
Or:  
BCF (aquatic) ≥ 500 
EC 2008 
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3 Limitations of the current regulatory criteria for bioaccumulation 
assessment 
According to current legislations in Canada, the US, and the EU as well as international conventions 
and protocols (see Table 1), screening and assessment of bioaccumulation potential is usually 
addressed by means of two quantitative criteria (in addition to other criteria for which no cut-off 
value is provided): 1) BCF or BAF data in aquatic species greater than a certain value; or, in absence 
of such experimental/empirical data, 2) log Kow greater than a certain value.  
Several authors have recently reviewed the limitations of these regulatory metrics and related 
criteria. Solutions to fulfil the gaps have also been proposed in the scientific literature. A summary of 
the current understanding is provided in the following sub-sections. 
3.1 Highly hydrophobic substances 
As reviewed by Ehrlich et al. (2011), the linear relationship between log Kow and BCF seems not to 
apply to highly hydrophobic substances as BCF levels tend to either level off or decline at log Kow 
higher than 5.5-6. This phenomenon is known as 'hydrophocity cut-off' and is still under debate. 
Some Authors mechanistically explained this phenomenon with the steric factors due to excessive 
molecular size and consequent reduction of gill permeation ability of the substances or cellular 
uptake. Based on this assumption, chemicals with log Kow above 8 or 10 are commonly considered as 
not likely to bioaccumulate (Dimitrov et al. 2004). ECHA also concludes that the aquatic BCF of a 
substance is unlikely to be > 2000 L/Kg (i.e. higher than the threshold value for classification of a 
substance as 'bioaccumulative' under REACH) if the available log Kow is > 10 (ECHA 2012a). 
Various criteria based on molecular size and related cut-off values have been proposed in the 
literature to explain reduced bioconcentration for larger and more hydrophobic substances such as 
molecular weight (> 700-1000 g/mol), effective diameter (> 0.95 nm), and maximum diameter (> 1.5 
nm) (Dimitrov et al. 2003; 2004; Nicholson et al. 2009). Arnot et al. (2009) critically review the 
proposed criteria and conclude that cut-off values based on molecular size are not supported by the 
available data and should not be used in a regulatory context. The Authors suggest that an 
integrated, holistic approach is applied to account for competing rates of uptake and elimination in 
an organism to assess bioaccumulation rather than applying molecular attributes (including 
consideration of bioavailability, dissociation in water, biotransformation, and dietary exposure) 
(Arnot et al. 2009). For example, Arnot and Gobas (2003) explain the reduction in BAF values with 
increasing Kow for very hydrophobic substances (i.e. log Kow > 7.5) by the reduction in bioavailability in 
water. Based on the results obtained from their BAF-QSAR model, Arnot and Gobas (2003) indeed 
argue that BAF values decrease at high Kow due to an increase in the chemical's sorption coefficient 
to particulate and dissolved organic carbon, not because of steric factors or lack of biomagnification. 
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Other Authors have challenged the 'hydrophobicity cut-off' phenomenon and ascribed it to 
experimental artefacts, i.e. non-equilibrium conditions and 'third phase' effect (as argued by Jonker 
and van der Heijne (2007) and subsequently critically discussed in Yang and Zeng (2008) and in 
Jonker and van der Heijden's reply (2008)). Specifically, Jonker and van der Heijne (2007) conclude 
that bioaccumulation of very hydrophobic compounds does occur and is controlled by 
hydrophobicity up to log Kow values of 7.5 at least (if BCF is properly measured and the test is 
properly conducted, e.g. by using a passive sampler and prolonging exposure time). The Authors 
suggest that the current regulatory criteria and the assumption of the 'hydrophobicity cut-off' are 
reconsidered, as the actual bioaccumulation for compounds with log Kow > 6 may be underestimated 
(Jonker and van der Heijne 2007). 
3.2 Biotransformation 
Metabolism appears to be the most important factor mitigating bioconcentration (Dimitrov et al. 
2005). Ehrlich et al. (2011) point out that other processes such as retarded elimination, bioactivation, 
and production of metabolites with comparable bioaccumulation potential as the parent compound 
may occur and should be considered in addition to metabolism. Bioaccumulation potentials 
estimated from Kow do not take into account any biotransformation of chemicals in organisms such as 
excretion, depuration, metabolism, thus potentially leading to false positives (e.g. Gobas et al. 2009). 
A Kow-based approach is therefore mainly applicable for poorly metabolised organic chemicals.  
The possibility to use bioaccumulation models to determine a cut-off value for metabolism (km) to be 
applied to BCF/BAF for correction, has been proposed and discussed in the literature (e.g. Arnot and 
Gobas 2003; Nichols et al. 2007; Arnot et al. 2008; Cowan-Ellsberry et al. 2008; Nichols et al. 2009). 
Based on the fact that the currently available km values are highly context-specific and the 
relationship between km and actual metabolism is quite complex, Arnot et al. (2008) conclude that 
the best option would be to apply km estimates on a chemical by chemical basis when in vivo 
bioaccumulation data are also available.  
3.3 Dietary exposure 
Both experimentally determined aquatic BCF values and predicted Kow values quantify the extent to 
which the chemical exchange between water and biota occurs, and are therefore based on the 
steady state lipid-water partitioning approach. However, studies (e.g. Connolly and Pedersen 1988; 
Gobas et al. 1993; 1999) demonstrate that this is not the only mechanism driving bioaccumulation as 
also food digestion and absorption cause ingested chemicals to magnify in the gastrointestinal tract 
against the thermodynamic gradient if the elimination/metabolism rates are low (dietary 
bioaccumulation). Consequently, the use of criteria based on BCF or Kow values can underestimate 
the real bioaccumulation and generate false negatives. This particularly applies to highly hydrophobic 
substances (high Kow, low solubility) for which exposure via diet or ingestion of e.g. soil/sediment 
gains more importance than via water (Ehrlich et al. 2011).  
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Recently, the OECD 305 Test Guideline (TG) Bioaccumulation in Fish: Aqueous and Dietary Exposure 
has been adopted (OECD 2012). This Test Guideline has been updated in order to incorporate dietary 
exposure and therefore enable determination of bioaccumulation potential of very poorly water 
soluble substances. The test allows for the determination of a laboratory dietary BMF. In Annex 8 
'Approaches to estimate tentative BCFs from data collected in the dietary exposure study' 
suggestions are given in case a BCFk needs to be derived from the depuration rate measured in the 
dietary study. Specifically, Annex 8 suggests that a combination of models are applied to obtain a 
range of values for the uptake rate (k1) and related BCF. It is also recommended that these 
estimations are treated in a weight of evidence approach along with the laboratory dietary BMF 
value and other information (e.g. molecular size) in order to obtain an overall picture of the 
bioaccumulation potential of the substance (OECD 2012). An equation to calculate BCFk from BMF 
was proposed by Weisbrod et al. (2009). This is a rough estimation of BCFk but may facilitate the 
application of the dietary test results in a regulatory context (Ehrlich et al. 2011). 
3.4 Air-respiring organisms 
The Kow and aquatic BAF/BCF values do not take into account bioaccumulation potential in air-
respiring organisms such as birds, mammals and humans, which is based on the organism-to-air 
exchange (Gobas et al. 2009; Ehrlich et al. 2011; Goss et al. 2013). Moreover, intake via food is 
generally the dominant route of exposure in non-aquatic organisms (Solomon et al. 2013). Another 
important factor to account for is that birds, mammals and humans are homeotherms7. Several 
Authors (e.g. Branue et al. 1989; Fisk et al. 2001; Hop et al. 2002) report that homeotherms have 
higher energy requirements, feeding rates, trophic positions, longer life time and different 
biotransformation abilities than poikilotherms8 (including fish), and therefore extrapolation from 
fish-related bioaccumulation data to other organisms should not be made (Martin et al. 2003a). In 
particular, Kelly et al. (2007) explain that higher biomagnification of certain organic compounds in 
air-breathing organisms is due to the greater ability to absorb and digest their diet, which is related 
to differences in digestive tract physiology and body temperature. The state-of-the-art on this 
subject is covered under Section 4 and 5. 
3.5 Proteinophilic substances 
Proteinophilic substances are substances that tend to accumulate in protein-rich tissues rather than 
lipids. Some Authors suggest that the traditional equilibrium partitioning may not be fully 
appropriate for substances that are amphiphilic (i.e. both hydrophobic and oleophobic) and show 
                                                            
7 Organisms that maintain their body temperature at a constant level by its metabolic activity, regardless the external 
influence (e.g. birds, mammals). 
8 Organisms that cannot regulate their body temperature except by behavioural means (e.g. reptiles, fish).  
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different mechanisms of bioaccumulation as well as target organs (e.g. Martin et al. 2003a; 2003b; 
Houde et al. 2006; Conder et al. 2008; Haukas et al. 2007; Ehrlich et al. 2011; Goss et al. 2013; Nh and 
Hungerbuhler 2013). Specifically, perfluorinated acids (e.g. PFOS) were found to preferentially 
accumulate in protein-rich tissues such as blood, liver and kidney rather than lipids and to have 
affinity to plasma albumin and hepatic proteins such as fatty acids-binding proteins (e.g. Martin et al. 
2003a; 2003b; Jones et al. 2003; Conder et al. 2008; Ng and Hungerbuhler 2013). In addition to that, 
Kow is problematic to measure due to the tendency of surfactants to aggregate at the aqueous-
organic interface (Martin et al. 2003a; Conder et al. 2008). OECD (2002) states as follows: 'Due to the 
surface-active properties of PFOS and the test protocol itself, PFOS forms three layers in 
octanol/water and hence, an n-octanol/water (Kow) partition coefficient cannot be determined. 
Consequently, the various physicochemical properties (e.g., bioconcentration factor, soil adsorption 
coefficient), which can usually be estimated for conventional organic compounds utilizing Kow 
equations, cannot be estimated, and a calculated (estimated) log Kow cannot be trusted. Even if the 
log Kow were known, it may not be appropriate for predictive purposes, e.g., bioconcentration. 
Studies on laboratory rats indicate that PFOS does not bioconcentrate in the lipid fraction. Instead, it 
tends to bind to certain proteins'. 
Martin et al. (2003a; 2003b) report that half-lives, uptake rates and BCF values of perfluorinated 
acids increase with increasing length of the perfluoroalkyl chain with perfluorosulfonates (PFSAs) 
showing higher values than the corresponding perfluorocarboxylates (PFCAs) of equivalent 
perfluoroalkyl chain length. Based on these findings, the Authors suggest that the hydrophobicity of 
these substances could be better predicted by the perfluoroalkyl chain length (Martin et al. 2003a; 
2003b) rather than Kow. They also considered the Critical Micelle Concentration (CMC) (as initially 
suggested by Tolls and Sijm (1995)) and found that bioaccumulation potential of perfluorinated acids 
increase with decreasing CMC. However, as neither hydrophobicity nor CMC alone can explain the 
highest bioaccumulation potential of PFSAs relative to PFCAs of equivalent chain length, the Authors 
recommend that the acid function of the substance is also considered as determining parameter 
(Martin et al. 2003a; 2003b). Similar results and considerations from different studies have been 
reported in subsequent reviews (Hounde et al. 2006; Conder et al. 2008). Conder et al. (2008) 
explicitly state that Kow-based regulatory criteria are inappropriate for predicting bioaccumulation 
potential of perfluorinated acids. Similarly, Kitano (2007) also concludes that both BCF and Kow are 
not applicable as bioaccumulation potential descriptors to PFOS.  
However, the scientific debate on the appropriateness of the equilibrium partitioning approach to 
characterise bioaccumulation potential of perfluorinated acids is still on-going and further empirical 
investigation is needed to fully understand the underlying mechanism and develop validated models.  
Some Authors have recently attempted to include protein associations in bioaccumulation modelling 
of perfluorinated acids. For example, Kelly et al. (2009) suggest that kinetics of perlfuorinated acids 
may be more accurately represented by two different parameters, which are the protein-water 
partitioning coefficient (Kpw) and the protein-air partitioning coefficient (Kpa). In addition, the Authors 
propose that biomagnification is evaluated by TMFs based on protein-normalised concentrations in 
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food web organisms. Ng and Hungerbuhler (2013) have recently developed a bioconcentration 
model in fish that for the first time explicitly considers interactions of perfluorinated acids with 
proteins including: i) binding to serum albumin in blood and interstitial fluids; ii) binding to cytosolic 
Fatty Acid Binding Proteins (FABPs) in the liver; and iii) renal clearance facilitated by Organic Anion 
Transporters (OATs). The Authors remark that deep understanding and modelling of protein binding 
is key for providing the full picture on the bioaccumulation potential of perfluorinated acids (Ng and 
Hungerbuhler 2013).  
Different views are reported by Webster and Ellis (2011) and Armitage et al. (2013). According to 
these Authors, the traditional equilibrium partitioning approach and related models are appropriate 
for perfluorinated acids. Webster and Ellis (2011) remark that: i) the amphiphilic/charged/surface 
active nature of surfactants is a property of the anion but not of the neutral species; ii) 
bioaccumulation of the neutral species is dominant due to larger Kow compared to the one of the 
anionic species (regardless the relative fractions in the medium); and iii) octanol is a sufficient 
surrogate of any organic phase and Kow can therefore be used to predict the bioaccumulation 
potential of any substance regardless its preference for lipids or protein-rich tissues. Webster and 
Ellis (2011) algebraically demonstrate that standard hydrophobically-driven equilibrium partitioning 
models are valid for perfluorinated acids and usable without modification. Their model for BCF 
prediction is based on two physico-chemical properties: pKa (as measured in the study performed by 
Burns et al. (2008)) and Kow of the neutral species (adjusted by the fraction of neutral species at 
biological pH). More recently, a mechanistic model to predict bioconcentration of ionogenic organic 
chemicals in fish has been proposed by Armitage et al. (2013). This model relies on the existing 
mechanistic framework for neutral organic chemicals (i.e. bioaccumulation as net result of uptake 
and elimination), which was modified to account for: i) dissociation and relative fractions of neutral 
and charged species; ii) transport of charged species across the gill (as illustrated by Shore et al. 
(1957)); and iii) preferential sorption of charged species to phospholipids (as demonstrated by: 
Lehmler and Bummer (2004); Lehmler et al. (2006); Xie et al. (2010a; 2010b)). This study highlights 
the importance of considering the interaction of charged species with phospholipids for prediction of 
bioaccumulation of ionogenic organic chemicals but also calls for further empirical investigations 
(Armitage et al. 2013). The Authors state that interaction with site-specific proteins can be included 
in the model using the volume fraction of proteins and estimated distribution ratios for the charged 
species (Armitage et al. 2013). However, it is recommended that the effect of competition for binding 
sites with endogenous and exogenous ligands as well as differences among tissues are considered 
when protein binding is modelled (as previously noted by: Jones et al. (2003); Han et al. (2005)). 
3.6 Data availability 
The availability of experimentally measured BCF and BAF values in the literature is limited (Arnot and 
Gobas 2006; Arnot and MacKay 2008; Gobas et al. 2009). However, in a regulatory context like the 
European REACH Regulation and Biocidal Products Regulation (BPR), screening criteria can be used to 
decide whether additional information on the bioaccumulation potential must be generated. 
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3.7 Technical issues 
Bioconcentration tests are difficult to perform, especially for highly hydrophobic, very poorly water 
soluble organic substances (e.g. adsorption to test containers); moreover, bioconcentration tests are 
time consuming (e.g. for highly hydrophobic substances several months may be necessary to reach 
the steady state) and costly (Gobas et al. 2009).  
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4 Evidence of bioaccumulation in non-aquatic organisms 
Both log Kow and BCF/BAF criteria in European and international legislation largely apply to aquatic 
(or water-respiring) organisms without taking into account that certain substances might have a 
larger bioaccumulation potential in non-aquatic food chains than in aquatic ones or be 
bioaccumulative only in non-aquatic (or air-respiring) organisms, including humans.  
In the past, studies on bioaccumulation in non-aquatic organisms were sporadic. Some examples are: 
Salisbury et al. (1992); Thomas et al. (1992); Landers et al. (1995); and Wong (1995). According to a 
recent review (Gobas et al. 2009), more systematic research has been carried out in the last years, 
including experimental studies and models aimed to support the identification of bioaccumulative 
substances in non-aquatic food webs and thus demonstrate the limits of the current regulatory 
bioaccumulation assessment (e.g. Kelly and Gobas 2001; 2003; Gobas et al. 2003; Armitage and 
Gobas 2007; Kelly et al. 2007; Tonnelier et al. 2011). The following paragraphs report and discuss the 
main literature findings in the field of bioaccumulation in non-aquatic food webs, including examples 
of substances that show higher and/or different bioaccumulation potential in non-aquatic organisms 
(including humans) compared to aquatic ones (see Table 2 for a summary). 
The research and monitoring carried out for POP in remote areas like the Artic Sea and Northern 
Canada indicates differences in bioaccumulation patterns of POPs and organochlorides between 
poikilotherms (including fish, crustaceans) and homeotherms (including air-breathing organisms such 
as birds and mammals) in various food chains.  
Among the others, Fisk et al. (2001) calculated TMF and BMF values for several POPs measured in 
different species of a Canadian Arctic marine food web. The Authors underline that TMF values for 
food webs including only poikilotherms (i.e. zooplankton and fish) are lower than TMF for food webs 
including both poikilotherms and homeotherms (i.e. seabirds and/or mammals). BMF values are also 
much higher in seabirds and mammals than in fish and zooplankton. The greater bioaccumulation 
showed by homeotherms is attributed to their greater energy requirements and subsequent feeding 
rates, suggesting that birds tend to bioaccumulate contaminants more than mammals (Fisk et al. 
2001).  
Hop et al. (2002) calculated TMF and BMF values for several POPs in the Barents Sea and confirm the 
results previously reported by Fisk et al. (2001) for the Canadian Arctic. Specifically, the higher 
biomagnification of β-hexachlorocyclohexane (β-HCH), oxychlordane, cis-chlordane, p,p'-
dichlorodiphenyldichloroethylene (p,p'-DDE), and polychlorinated biphenyl (PCB) from 47 to 1539 in 
homeotherms than in poikilotherms is related to higher energy requirements, higher trophic 
                                                            
9 Authors do not report Kow values of investigated substances. 
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position, longer life-span, and negligible direct exchange with seawater across respiratory surfaces 
(Hop et al. 2002).  
Borgå et al. (2001) studied biomagnification patterns of organochlorides along a Barents Sea food 
chain and found lower concentrations of organochlorides such as ΣHCHs (log Kow = 3.910) and 
hexachlorobenzene (HCB) (log Kow = 5.2), ΣChlordanes (log Kow = 6.1-6.4), 
dichlorodiphenyltrichloroethane (ΣDDTs) (log Kow = 5.7), ΣPCBs (log Kow = 28-153) in pelagic 
crustaceans and fish than in sea birds (i.e. one to three orders of magnitude less). The low 
concentrations in crustaceans and fish are attributed to their ability to eliminate contaminants by 
diffusion to water. It is also noticed that the organochlorine pattern change moving up the food 
chain. Specifically, the relative contribution of α-HCH and γ-HCH to ΣHCHs, HCB, and cis-chlordane 
and trans-nonachlor to ΣChlordanes decreases while the relative contribution of their metabolites 
(i.e. β-HCH and oxychlordane) as well as more persistent compounds (i.e. ΣDDTs and ΣPCBs) 
increases. These results reflect the different elimination potentials between poikilotherms such as 
crustaceans and fish, which eliminate contaminants through direct diffusion via water, and 
homeotherms such as seabirds, which exhibit higher metabolic rates and consequently higher ability 
to metabolise contaminants (Livingstone 1992; Livingstone et al. 1992; Borga et al. 2001). Hoekstra 
et al. (2003), who studied trophic transfer of organochlorides in an Arctic marine food web located in 
Alaska, also support this conclusion.  
In a review of the mechanisms and models of intestinal absorption and bioaccumulation of organic 
chemicals in wildlife and humans, Kelly et al. (2004) underline that BMFs in homeotherms are higher 
than those in poikilotherms organisms and follow different relationships with the physico-chemical 
properties of chemicals for two main reasons: i) efficient gastrointestinal absorption; and ii) very 
slow respiratory elimination to the air. Accordingly, the Authors recommend further investigations 
into the mechanisms of bioaccumulation in homeotherms and reconsideration of the current 
regulatory initiatives where the fundamental processes controlling biomagnification in air-breathing 
homeotherms are not fully recognised (Kelly et al. 2004). 
The question of whether chemicals with log Kow < 5 (i.e. classified as 'not bioaccumulative' in aquatic 
species according to the Stockholm Convention on POPs as illustrated in Table 1) can exhibit an 
ability to biomagnify in non-aquatic food webs was first explicitly addressed by Kelly and Gobas 
(2001)11. A field study showed that some persistent but less hydrophobic substances can 
substantially biomagnify in the Arctic lichens-caribou-wolf terrestrial food chain despite of their low 
log Kow and therefore in contrast to what occurs in aquatic food chains. Specifically, the Authors 
compared the bioaccumulation of organic compounds with different log Kow values to investigate 
                                                            
10 Authors report log Kow values compiled from the literature. 
11 Authors state that Kow values were compiled from the literature (available as Supporting Information). 
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congener-specific bioaccumulation patterns. β-HCH (log Kow = 3.81) shows evidence of 
bioaccumulation in the whole Arctic lichens-caribou-wolf food chain. In particular, it appears that 
caribou and wolves do not efficiently eliminate β-HCH. 1,2,4,5 tetrachlorobenzene (1,2,4,5 TCB) (log 
Kow = 4.70) also shows evidence of biomagnification in the whole Arctic lichens-caribou-wolf food 
chain.  
Subsequently, Kelly and Gobas (2003)12 developed a mechanistic model to predict BMF values of 
POPs in the Arctic lichens-caribou-wolf terrestrial food chain. The model's results show that 
moderately hydrophobic and non-metabolisable organic compounds such as β-endosulfan (log Kow = 
3.7), β-HCH (log Kow = 3.8) and 1,2,4,5 TCB (log Kow = 4.6) can biomagnify in the terrestrial mammals 
food chain and in some cases exhibit greater BMF values than more hydrophobic substances. The 
Authors suggest that the negligible respiratory elimination via exhalation to the air of these organic 
compounds may be responsible for this phenomenon (Kelly and Gobas 2003).  
In a review of mechanisms and models of intestinal absorption and bioaccumulation of organic 
chemicals in wildlife and humans, Kelly et al. (2004) report a list of polar non-volatile compounds that 
do not biomagnify in aquatic organisms (i.e. log Kow < 5) but may substantially biomagnify in air-
breathing organisms, unless they are sufficiently metabolised at a significantly high rate or 
depurated by urinary excretion. The list include: HCHs, endosulfan, atrazine, bis-4-chlorophenyl 
sulfone (BCPS), trischlorophenyl methanol (TCPMeOH), perfluoroctane sulfonate (PFOS)13.  
In 2007, Kelly et al. measured concentrations of organic contaminants of varying hydrophobicity in a 
piscivorous food web (water-respiring organisms only), a terrestrial food web (air-breathing 
organisms only) and a marine mammalian food web (including water- and air-breathing organisms) 
from northern Canada. Compounds characterised by low estimated log Kow values14 such as β-HCH 
(log Kow = 3.8), 1,2,4,5-TCB (log Kow = 4.7), β-endosulfane (log Kow = 3.7), dicofol (log Kow = 3.5), musk 
xylene (log Kow = 4.1), trifluralin (log Kow = 4.4), and tetradifon (log Kow = 4.6) do not biomagnify in the 
piscivorous food web but in the terrestrial food web and in the air-breathing organisms of the 
marine mammalian food web. The Authors report that air-breathing organisms exhibit greater 
ability to absorb and digest their diet than water-respiring organisms, which is related to differences 
in digestive tract physiology and body temperature (Kelly et al. 2007). 
Humans being at the top of both aquatic and non-aquatic food webs are particularly exposed to 
persistent pollutants in the environment (Czub and McLachlan 2004a). A mechanistically-based, non-
steady state model developed by Czub and McLachlan (2004a; 2004b) predicts less hydrophobic but 
                                                            
12 Authors state that Kow values are calculated at 20°C and results are comparable to reported values in the literature. 
13 Authors do not report Kow values of investigated substances. 
14 Authors state that Kow values were compiled from the literature and temperature-corrected. 
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non-volatile substances such as atrazine, mecoprop, 2,4-dichlorophenossiacetic acid, γ-HCH, and 
phenantrene as bioaccumulative in humans despite their log Kow lower than 515. The Physiologically 
Based Toxicokinetic model for screening of chemicals with human bioaccumulative potential 
developed by Tonnelier et al. (2011) confirms high bioaccumulation potential in humans for PCBs16 
(log Kow ranging from 6.6 to 7.65), DDTs (log Kow = 6.91), and PFOS (log Kow = 6.28), in line with the 
available literature. In addition, pesticides such as emamectin (log Kow = 5.0), buprofezin (log Kow = 
4.3), fenvalerate (log Kow = 6.2), parathion (log Kow = 3.83), cypronidil (log Kow = 4.0), pyraclostrobin 
(log Kow = 5.45), fipronil (log Kow = 4.0), and bromacil (log Kow = 2.11) show high bioaccumulation 
potential in humans despite their low BCF values in fish (< 1700 Kg/L) and relatively low log Kow 
values (most of them lower than 4.3).  
Some of the chemicals mentioned above are classified as bioaccumulative and currently banned or 
restricted under the Stockholm Convention on POPs (UNEP 2001; 2009) (see Section 2, footnote 4). 
PCBs, DDTs, chlordane, and HCB are part of 'the dirty dozen', which is the original list compiled in 
2001. A few substances such as PFOS, C-Octabromodyphenil ether (Octa-BDE), lindane, α-HCH and β-
HCH were added later in 2009. Endosulfan (and its isomers) was included in 2011. Many of these 
substances are pesticides, which are strongly related to terrestrial food chains. It is indeed pointed 
out that substances like PCBs and DDTs were most affecting non-aquatic organisms and the effects 
were more evident on birds and mammals rather than fish (Gobas et al. 2003). In a Discussion Paper 
on Bioaccumulation Evaluation prepared for the POPs Review Committee Third Meeting in 2007, 
Kitano points out that substances such as lindane, α-HCH, β-HCH, and OctaBDE fulfil the screening 
criteria of the Stockholm Convention on POPs despite their low BCF values (< 5000 L/Kg) as they 
show evidence of bioaccumulation in non-aquatic organisms. The following evidences are reported in 
the Kitano's discussion paper: i) detection of high concentrations of substances having BAF/BCF 
values <5000 L/kg in tissues of Arctic seabirds and mammals; ii) detection in breast milk and placenta 
tissues in mammals; iii) detection in bird eggs; iv) detection in breast milk and placenta tissues in 
humans; v) BMF values higher than 1 for different trophic levels including upper trophic levels (e.g. 
mammals) of marine and terrestrial food webs; vi) high half-life in humans; vii) high soil-organism 
bioaccumulation factor.  
Substances such as 1,2,4,5-TCB, oxychordane, dicofol, musk xylene, trifluralin, and tetradifon are still 
not covered by the Stockholm Convention on POPs. However, musk xylene is a Substance of Very 
High Concern (SVHC) included in the REACH Candidate List for Authorisation because of its vPvB 
properties. According to ECHA (2008), the vB assignment is based on a key study reporting a number 
of BCF values in fish, some of them greater than 5000 Kg/L. Bioaccumulation in terrestrial organisms 
                                                            
15 Authors do not report log Kow values for the investigated substances. However, Figure 6 in Czub and McLachlan (2004b) 
shows these substances as characterised by log Kow lower than 5. 
16 Physico-chemical properties including log Kow are estimated by EPI Suite v4.0 (US EPA 2011). 
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was estimated but not taken into account in the conclusion. Some recent publications also confirm 
musk xylene's bioaccumulation potential in aquatic organisms. 
Table 2. List of substances for which there is evidence of bioaccumulation in non-aquatic organisms (and 
homotherms) as reported in the scientific literature. Kow = octanol-water partitioning coefficient. 
Substance name Log Kow Evidence on bioaccumulation in non-aquatic organisms 
(and homeotherms) 
Reference 
Not 
reported 
Evidence of higher biomagnification in homeotherms 
than poikilotherms in Barents Sea and Canadian Arctic 
Fisk et al. 2001 
Hop et al. 2002 
3.81 Evidence of bioaccumulation in Arctic lichens-caribou-
wolf food chain 
Kelly and Gobas 
2001 
3.8 Predicted biomagnification in Arctic lichens-caribou-wolf 
food chain 
Kelly and Gobas 
2003 
3.8 Evidence of biomagnification in terrestrial food web and 
air-breathing organisms of marine mammalian food web 
from Northern Canada 
Kelly et al. 2007 
β-hexachlorocyclohexane 
(β-HCH) 
< 5 Predicted as bioaccumulative in humans Czub and 
McLachlan 2004a;b 
3.9 Higher concentrations in sea bids than pelagic 
crustaceans and fish in Barents Sea 
Borga et al. 2001 Σhexachlorocyclohexane
s (ΣHCH) 
< 5 May substantially biomagnify in air-breathing organisms Kelly et al. 2004 
Oxychlordane Not 
reported 
Higher biomagnification in homeotherms than 
poikilotherms in Barents Sea and Canadian Arctic 
Fisk et al. 2001 
Hop et al. 2002 
cis-chlordane Not 
reported 
Higher biomagnification in homeotherms than 
poikilotherms in Barents Sea and Canadian Arctic 
Fisk et al. 2001 
Hop et al. 2002 
Σchlordanes 6.1-6.4 Higher concentrations in sea bids than pelagic 
crustaceans and fish in Barents Sea 
Borga et al. 2001 
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Table 2. (cont.) 
Substance name Log Kow Evidence on bioaccumulation in non-aquatic organisms 
(and homeotherms) 
Reference 
p,p'-
dichlorodiphenyldichloro
ethylene (p,p'-DDE) 
Not 
reported 
Higher biomagnification in homeotherms than 
poikilotherms in Barents Sea and Canadian Arctic 
Fisk et al. 2001 
Hop et al. 2002 
Dichlorodiphenyltrichloro
ethane (ΣDDTs) 
5.7 Higher concentrations in sea bids than pelagic 
crustaceans and fish in Barents Sea 
Borga et al. 2001 
Polychlorinated biphenyl 
(PCB) from 47 to 153 
Not 
reported 
Higher biomagnification in homeotherms than 
poikilotherms in Barents Sea and Canadian Arctic 
Fisk et al. 2001 
Hop et al. 2002 
Polychlorinated biphenyl 
(PCBs) 
28-153 Higher concentrations in sea bids than pelagic 
crustaceans and fish in Barents Sea 
Borga et al. 2001 
Hexachlorobenzene 
(HCB)  
5.2 Higher concentrations in sea bids than pelagic 
crustaceans and fish in Barents Sea 
Borga et al. 2001 
4.70 Evidence of bioaccumulation in Arctic lichens-caribou-
wolf food chain 
Kelly and Gobas 
2001 
4.6 Predicted biomagnification in Arctic lichens-caribou-wolf 
food chain 
Kelly and Gobas 
2003 
1,2,4,5 
tetrachlorobenzene 
(1,2,4,5 TCB)  
4.7 Evidence of biomagnification in terrestrial food web and 
air-breathing organisms of marine mammalian food web 
from Northern Canada 
Kelly et al. 2007 
3.7 Predicted biomagnification in Arctic lichens-caribou-wolf 
food chain 
Kelly and Gobas 
2003 
< 5 May substantially biomagnify in air-breathing organisms Kelly et al. 2004 
β-endosulfan  
3.7 Evidence of biomagnification in terrestrial food web and 
air-breathing organisms of marine mammalian food web 
from Northern Canada 
Kelly et al. 2007 
< 5 May substantially biomagnify in air-breathing organisms Kelly et al. 2004 Atrazine 
< 5 Predicted as bioaccumulative in humans Czub and 
McLachlan 2004a;b 
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Table 2. (cont.) 
Substance name Log Kow Evidence on bioaccumulation in non-aquatic organisms 
(and homeotherms) 
Reference 
bis-4-chlorophenyl 
sulfone (BCPS) 
< 5 May substantially biomagnify in air-breathing organisms Kelly et al. 2004 
Trischlorophenyl 
methanol (TCPMeOH) 
< 5 May substantially biomagnify in air-breathing organisms Kelly et al. 2004 
Perfluoroctane sulfonate 
(PFOS) 
< 5 May substantially biomagnify in air-breathing organisms Kelly et al. 2004 
Dicofol  3.5 Evidence of biomagnification in terrestrial food web and 
air-breathing organisms of marine mammalian food web 
from Northern Canada 
Kelly et al. 2007 
Musk xylene 4.1 Evidence of biomagnification in terrestrial food web and 
air-breathing organisms of marine mammalian food web 
from Northern Canada 
Kelly et al. 2007 
Trifluralin 4.4 Evidence of biomagnification in terrestrial food web and 
air-breathing organisms of marine mammalian food web 
from Northern Canada 
Kelly et al. 2007 
Tetradifon 4.6 Evidence of biomagnification in terrestrial food web and 
air-breathing organisms of marine mammalian food web 
from Northern Canada 
Kelly et al. 2007 
Mecoprop < 5 Predicted as bioaccumulative in humans Czub and 
McLachlan 2004a;b 
2,4-
dichlorophenossiacetic 
acid 
< 5 Predicted as bioaccumulative in humans Czub and 
McLachlan 2004a;b 
Phenantrene < 5 Predicted as bioaccumulative in humans Czub and 
McLachlan 2004a;b 
Emamectin 5.0 High bioaccumulation potential in humans despite low 
BCF values in fish (< 1700 Kg/L) 
Tonnelier et al. 
2011 
Buprofezin  4.3 High bioaccumulation potential in humans despite low 
BCF values in fish (< 1700 Kg/L) 
Tonnelier et al. 
2011 
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Table 2. (cont.) 
Substance name Log Kow Evidence on bioaccumulation in non-aquatic organisms 
(and homeotherms) 
Reference 
Fenvalerate 6.2 High bioaccumulation potential in humans despite low 
BCF values in fish (< 1700 Kg/L) 
Tonnelier et al. 
2011 
Parathion 3.83 High bioaccumulation potential in humans despite low 
BCF values in fish (< 1700 Kg/L) 
Tonnelier et al. 
2011 
Cypronidil 4.0 High bioaccumulation potential in humans despite low 
BCF values in fish (< 1700 Kg/L) 
Tonnelier et al. 
2011 
Pyraclostrobin  5.45 High bioaccumulation potential in humans despite low 
BCF values in fish (< 1700 Kg/L) 
Tonnelier et al. 
2011 
Fipronil 4.0 High bioaccumulation potential in humans despite low 
BCF values in fish (< 1700 Kg/L) 
Tonnelier et al. 
2011 
Bromacil 2.11 High bioaccumulation potential in humans despite low 
BCF values in fish (< 1700 Kg/L) 
Tonnelier et al. 
2011 
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5 Literature criteria for screening and assessment of bioaccumulation in 
non-aquatic organisms 
The evidences reported in Section 4 and summarised in Table 2 suggest that current international 
and national regulatory systems, where only quantitative bioaccumulation criteria based on log Kow 
and/or aquatic BCF/BAF data are considered for screening purposes (see Table 1), may fail to identify 
a number of substances that have the potential of biomagnifying in non-aquatic food chains but not 
in aquatic ones. In Europe there has been improvement in the bioaccumulation assessment 
requirements under the REACH Regulation as additional qualitative criteria including 
'bioaccumulation in other organisms such as terrestrial organisms' and 'detected levels in human 
tissues' have been formally mentioned in the revised REACH Annex III (see Table 1). However, these 
criteria are subject to interpretation as no cut-off value is provided and there is currently no clear 
guidance on how to apply them in a weight of evidence approach (see Section 2). 
Several Authors (e.g., Kelly and Gobas 2001; 2003; Gobas et al. 2003; Kelly et al. 2004; Armitage and 
Gobas 2007; Kelly et al. 2007; Kitano 2007; Gobas et al. 2009; McLachlan et al. 2011; Tonnelier et al. 
2011) have therefore highlighted the need of incorporating new regulatory criteria or adjusting the 
existing ones, thus enabling the identification of substances that are potentially bioaccumulative in 
non-aquatic organisms (including humans) but not in aquatic ones. The following paragraphs 
describe and discuss the criteria and related threshold values, which have been suggested in the 
scientific literature (see Table 4 for a summary). 
5.1 Screening criteria 
The statistical analysis on the data collected in the experimental work in Canadian Arctic lichen-
caribou-wolf food chains carried out by Kelly and Gobas (2001) reveals the important relationship 
between Koa and BMF values in terrestrial mammals. The study shows statistically significant 
increases in the BMF values in wolves (but not in caribou due to their ruminant digestive system) 
with increasing Kow and Koa. The data suggest that wolves have an efficient digestive system and high 
uptake rate through the gastrointestinal tract, which is counterbalanced by elimination via air 
(exhalation). Consequently, non-metabolised hydrophobic substances with high Koa are eliminated 
slower via air (compared to substances with low Koa) and hence exhibit higher biomagnification (Kelly 
and Gobas 2001). Moreover, it is pointed out that the increase of BMF values with Koa is less than 
proportional. This phenomenon is ascribed to the expected reduction in uptake with increasing Kow of 
the substances (see Section 3.1), which seems to occur at a lower rate than the reduction in 
elimination via air with increasing of Koa and thus resulting in a less than proportional relationship 
between BMF and Koa (Kelly and Gobas 2001). The Authors indicate gastrointestinal absorption 
efficiencies (strongly dependent on Kow) and lipid-to-air elimination rates (strongly dependent on Koa) 
as two important parameters affecting POPs bioaccumulation and call for additional research that 
enables the identification of a regulatory threshold. 
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Based on these findings, the Authors used the same dataset to develop models for bioaccumulation 
of POPs in the Arctic terrestrial food web, and in a couple of follow-up papers explicitly propose that 
log Koa is included as a bioaccumulation predictor in current regulatory systems (Kelly and Gobas 
2003; Gobas et al. 2003). The models demonstrate that:  
• Predicted BAF values (lichens, caribou and wolves) increase with increasing Koa; 
• Predicted BAF values increase with trophic level, thus highlighting the importance of dietary 
uptake and biomagnification in the terrestrial food chains; 
• Log Koa is a better predictor of BMF values in non-aquatic organisms due to the importance of 
animal-to-air exchange: relatively hydrophilic and non-metabolised chemicals exhibit greater 
BMF values than more hydrophobic substances due to higher Koa and hence negligible 
respiratory elimination; 
• Non metabolised chemicals with log Koa lower than 5 do not biomagnify in terrestrial food 
chains (air respiration is the main route of elimination);  
• Chemicals with log Kow lower than 5 (i.e. not bioaccumulative in aquatic organisms according 
to the Stockholm Convention criteria) can biomagnify in terrestrial food chains; 
• Chemicals with log Koa higher than 5 can biomagnify in terrestrial food chains if log Kow is 
higher than 2 and metabolism is low (substances are very poorly eliminated into air as well as 
urine and bile);  
• Chemicals with high Koa but log Kow lower than 2 have a reduced biomagnification potential 
due to the efficient urine excretion; 
• BMF values in terrestrial food chains can be much greater than those in aquatic food chains 
(generally one order of magnitude greater); 
• BMF values for non-aquatic organisms do not exhibit a 'hydrophobicity cut-off' (i.e. no BMF 
maximum at log Kow ~ 7 and drop off with increasing Kow) as it is the case for aquatic 
organisms. This is because the dietary uptake efficiency in mammals and birds does not show 
the same reduction as in fish (this phenomenon is known as 'hydrophobicity cut-off' and is 
discussed in Section 3.1). 
Kelly et al. (2007) measured and compiled concentrations of organic contaminants of varying Kow in a 
piscivorous food web (water-respiring organisms only), a terrestrial food web (air-respiring organisms 
only) and a combined marine mammalian food web (including water- and air-respiring organisms) 
from northern Canada. The study confirms previous results, i.e.: 
• Less hydrophobic compounds (log Kow < 5) do not biomagnify in the piscivorous food web but 
show a high degree of biomagnification in the terrestrial food web and in air-breathing 
organisms of the marine mammalian food web; 
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• Air-breathing organisms exhibit higher BMFs than those in water-respiring organisms 
because of their greater ability to absorb and digest their diet; 
• The relationship between the BMF and chemical properties is controlled by the rate of 
elimination (in water-respiring organisms elimination becomes sufficiently slow for 
substances with log Kow < 5 whereas in air-respiring organisms this occurs when log Koa > 5 
and log Kow > 2). 
• In the terrestrial food web non-metabolised chemicals with a log Kow between 2 and 10 and 
log Koa > 6 can biomagnify (in contrast to the piscivorous food web where biomagnification 
does not occur for super-hydrophobic organic substances with log Kow > 8, which are 
absorbed at very slow rate); 
• Simulations of human dietary exposure of contaminants to the indigenous Inuit population of 
Northern Canada shows that biomagnification can occur for chemicals with a log Kow in the 
range 2-5 and log Koa > 6.  
In addition to previous studies, a mechanistic terrestrial food chain bioaccumulation model for POPs 
was developed and applied to the soil-earthworms-shrews system by Armitage and Gobas (2007). 
The results demonstrate that:  
• Substances with log Koa < 5 do not biomagnify in terrestrial vertebrates;  
• Substances with log Kow < 2 have no bioaccumulation potential;  
• Very hydrophobic substances with log Kow between 8 and 12 show BMF values greater than 1 
in this system;  
• Substances with log Kow between 4 and 10 and log Koa > 7 exhibit the greatest BMF values. 
According to the 2001-2007 literature, there seems to be a consensus in the scientific community 
on the importance of considering Koa as criterion to identify substances that may 
bioaccumulate/biomagnify in non-aquatic food chains including humans. Specifically, two main 
implications from a regulatory point of view can be pointed out.  
The first implication is that substances characterised by log Kow in the range 2-5 and log Koa > 5 
represent a new group of potentially bioaccumulative substances that may not be identified by the 
criteria used e.g. under the Stockholm Convention (i.e. bioaccumulative if log Kow > 5) or the Canadian 
Environmental Protection Act (i.e. bioaccumulative if log Kow > 5) and currently suggested in the ECHA 
Guidance on information requirements and chemical safety assessment. Chapter R.11: PBT 
assessment (i.e. non bioaccumulative if log Kow < 4.5) (ECHA 2012a). According to Gobas et al. (2003), 
the 67% (i.e. two thirds) of approximately 12000 organic substances in the Canadian Domestic 
Substances List have low Kow but high Koa and are therefore neglected even if they have the potential 
to bioaccumulate in non-aquatic organisms. This implication may therefore have a large impact if 
considered in a screening/prioritisation exercise or incorporated into the regulatory criteria for 
PBT/vPvB assessment.  
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The second implication is that categorising very hydrophobic organic chemicals with a log Kow > 9-10 
as being non bioaccumulative due to the slow rate of absorption in aquatic organisms may neglect 
their high bioaccumulation potential in terrestrial food chains (Kelly and Gobas 2003; Gobas et al. 
2003; Armitage and Gobas 2007). In particular, Armitage and Gobas (2007) report BMF higher than 1 
for organic chemicals with log Kow in the range 8-12 with maximum BMF values for organic    
chemicals with log Kow in the range 4-10 and log Koa higher than 7. However, the 
bioaccumulation/biomagnification potential of highly hydrophobic substances in both aquatic and 
non-aquatic organisms and related cut-off values would need further research and discussion 
before specific provisions may be explicitly included into a regulatory framework. 
Finally, it has to be pointed out that Koa is also based on the equilibrium partitioning assumption to 
lipids. Therefore, Koa-based cut-off values are also affected by the same limitations as Kow-based 
ones in relation to substances that partition into other tissues, e.g. proteins, and may not be 
universally applicable as a screening method for the non-aquatic compartment (this issue is 
discussed in Section 3.5).  
5.2 Assessment criteria 
In January 2008 an international workshop sponsored by the Society of Environmental Toxicology 
and Chemistry (SETAC) was held in Pensacola (FL, USA). The workshop aimed at discussing scientific 
aspects related to persistence, bioaccumulation, toxicity and long-range transport in order to provide 
recommendations on how to use the available scientific information and foster the advancement of a 
sound scientific foundation for the regulatory criteria used to identify POP and PBT substances 
(Klečka et al. 2009). A series of three articles were published to address methods for the evaluation 
of the bioaccumulation potential including predictive approaches, in vivo laboratory tests and field 
studies (i.e. Nichols et al. 2009; Weisbrod et al. 2009; Gobas et al. 2009). One more article discussed 
the use of measurement data for the evaluation of exposure to wildlife and humans (Swackhamer et 
al. 2009). 
Nichols et al. (2009) reviewed the use of predictive approaches to investigate Adsorption Distribution 
Metabolism Elimination (ADME) processes and assess bioaccumulation including Quantitative 
Structure-Activity Relationships (QSARs) models, mass-balance models, food web bioaccumulation 
models and in vitro systems. The discussion centres on bioaccumulation assessment for fish but the 
Authors state that the same principles apply to bioaccumulation assessment for other animals, 
including terrestrial wildlife and humans (Nichols et al. 2009). The Authors acknowledge the 2001-
2007 literature led by Kelly, Gobas and co-workers addressing air-breathing organisms and 
suggesting Koa as an additional criterion for bioaccumulation assessment. In addition to that, the 
Authors suggest that modelling efforts for both aquatic and non-aquatic organisms consider multi-
media fate information to determine the medium of exposure based on the mode of entry into the 
environment (Nichols et al. 2009). The Authors conclude that a weight of evidence approach is 
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applied considering both in vitro data and computational prediction models, which is generic and 
applicable to both aquatic and non-aquatic organisms.  
Weisbrod et al. (2009) reviewed in vivo laboratory and field metrics that can be used to assess 
bioaccumulation in PBT substances and POPs identification. In particular, the Authors considered 
several bioaccumulation metrics that may be related to non-aquatic species:  
• Biota Soil/Sediment Accumulation Factor (BSAF); 
• Bioaccumulation Factor (BAF); 
• Biomagnification Factor (BMF);  
• Trophic Magnification Factor (TMF); and  
• Tissue residues vs Critical tissue residues.  
A conservative trigger value of 1 is recommended for BSAF, BMF and TMF because values above 1 
represent amplification above the expected bioaccumulation due to simple equilibrium partitioning 
(Weisbrod et al. 2009).  
The Authors state that results from soil exposure laboratory tests or field studies, which are 
typically reported as BSAF values, are useful for indicating whether the substance can accumulate 
from soil into organisms at the base of some food chains. A BSAF value > 1 indicates the substance 
may be bioaccumulative. However, the Authors point out that a BSAF value < 1 does not necessarily 
indicates a correlative BAF value will be low as field-based BAF values reflect steady-state 
conditions with multiple exposure routes. Moreover, BSAF values with soil organisms do not 
provide any insight into the potential of a substance for biomagnification along the food chain. 
Consequently, BSAF may be less likely to raise concern than other bioaccumulation metrics that 
inherently account for more exposure routes and trophic levels (Weisbrod et al. 2009). From a 
technical point of view, BSAF values are also subject to several limitations: i) 'aging' of the spiked soil; 
ii) non-equilibrium conditions may prevail due to spiking procedures; iii) BSAF is an endpoint 
composed of at least four underlying measurements (chemical concentration in soil/sediment, 
organic carbon fraction in soil/sediment, chemical concentration in biota, lipid fraction in biota), 
which causes considerable propagation of error; and iv) BSAF is a ratio between two non-polar 
phases (organic carbon and lipid), which renders it relatively insensitive to differences in compound's 
hydrophobicity (Weisbrod et al. 2009). 
In this context, it is worth to mention that there are tools such as the OECD Test Guideline (TG) 317 
on Bioaccumulation in Terrestrial Oligochaetes, which are already available (OECD 2010). As 
extrapolation from aquatic bioaccumulation data to non-aquatic organisms is difficult, if not possible, 
and earthworms (Oligochaetes) represent a food source for several organisms including vertebrates 
e.g. foxes and gulls (OECD 2010), the OECD TG 317 may help with obtaining an indication of the 
bioaccumulation potential for low trophic levels of the non-aquatic food chains. In the OECD TG 317, 
various uptake routes are considered (i.e. not only direct contact with chemicals in the soil solution 
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through the outer skin but also exposure to soil-bounded chemicals via ingestion of soil particles) and 
results can be reported as BAF (Kgsoil/Kgworm) and, additionally, as BSAF 
(Kgsoilorganiccarbon/Kgwormlipidcontent). The OECD TG 317 is applicable to both organic chemicals, including 
very hydrophobic substances with log Kow > 6, and metals.  
The current version of the ECHA 'Guidance on information requirements and chemical safety 
assessment. Chapter R.7c: Endpoint-specific Guidance' advises that BSAF may be a misleading 
indicator as it also reflects sorption behaviour and suggests that BCF based on freely dissolved 
chemical concentrations in soil pore water could be a better choice (ECHA 2012b). A mechanistic 
approach for estimating bioconcentration of organic chemicals in earthworms was proposed by Jager 
in 1998. More recently, the model has been tested and assessed by Brooke and Crookes (2007). 
ECHA suggests its application under the REACH Regulation (ECHA 2012b; 2012c17). According to 
ECHA, BCF data from sediment-dwelling organisms may also be used as surrogate for terrestrial 
earthworms data on a case-by-case basis provided that any differences in organic carbon and pore 
water content between sediment and soil is taken into account (ECHA, 2012b). 
Finally, Solomon at al. (2013) have recently concluded that BSAF and BCF in soil could be used as 
criteria to assess bioaccumulation in non-aquatic organisms provided that a normalisation procedure 
is established to account for the matrix influence. 
BAF determined in the field is a more ecologically relevant metric as it reflects steady-state 
conditions and bioaccumulation from multiple routes of exposure, including the diet. For this reason, 
BAF values are usually higher than corresponding BCF values for the same species (Arnot and Gobas 
2006; Weisbrod et al. 2009) and should be preferred over BCF, when available (Arnot and Gobas 
2006). A drawback is that BAF data are largely variable and affected by a number of site-specific 
environmental conditions (Weisbrod et al. 2009) as well as analytical factors (Arnot and Gobas 2003; 
Gobas et al. 2009). Moreover, BAF data are not available for most chemicals in commerce (Arnot and 
Gobas 2006). It is worth to notice that a QSAR-based model that could be used for regulatory 
purposes was developed by Arnot and Gobas (2003) (see also Costanza et al. (2012)). The model can 
be adapted to consider metabolic rate. However, it only predicts bioaccumulation potential in 
aquatic food webs and caution is required when it is applied to charged or ionic compounds (Arnot 
and Gobas 2003). It needs to be pointed out that all consulted literature sources that discuss the use 
of field-based BAF as regulatory criteria refer to aquatic species. 
BMF is considered as a more powerful metric as it gives an insight into dietary exposure and 
biomagnification potential of a substance, which seems to be a major concern for higher trophic 
levels in both aquatic and terrestrial food webs. According to Weisbrod et al. (2009), substances with 
BMF values higher than 1 exhibit potential for biomagnification and substances with BMF values 
                                                            
17 A consultation procedure is currently on-going to update the guidance documents. Link to the ECHA website where the 
last drafts are available: http://echa.europa.eu/support/guidance/consultation-procedure/ongoing-reach. 
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lower than 1 may undergo trophic dilution. However, the Authors point out that BMF values focus 
on single trophic relationships and may largely vary among studies and species, especially if field-
based (Weisbrod et al. 2009).  
TMF is the most comprehensive metric for understanding the biomagnification potential of a 
substance as it represents the average increase or decrease of concentration levels in a food chain: 
a TMF higher than 1 indicates that the substance biomagnifies in the food web (i.e. concentration 
increases with trophic level); a TMF lower than 1 indicates that the substance undergoes trophic 
dilution (Weisbrod et al. 2009). However, the Authors highlight that TMF values are also affected by 
some assumptions (Weisbrod et al. 2009). For example, one assumption is that all organisms have 
similar metabolism efficiency but e.g. poikilotherms and homeotherms are known to have different 
metabolic capabilities. The consequence is that the TMF value may overestimate or underestimate 
the degree of biomagnification in poikilotherms and homeotherms, respectively (Weisbrod et al. 
2009).  
The Authors also suggest the use of contaminant body burden (or tissue residue) as field metric for 
bioaccumulation assessment. These values can be considered as surrogate for the internal dose and 
can be compared to known critical body burdens (or critical tissue residues) derived from laboratory 
acute or chronic toxicity studies, thus allowing calculation of hazard quotients and prediction of risk 
(Weisbrod et al. 2009). Weisbrod et al. (2009) propose 0.1 or 0.01 as threshold value when acute or 
chronic critical body burdens (or critical tissue residues) are used but do not discuss such numbers. 
Weibrod et al. (2009) propose benchmark values or approximate maximum values for several 
bioaccumulation metrics. Table 3 illustrates the benchmark values for metrics that are relevant for 
non-aquatic organisms. Data that exceed these values or limits should be critically evaluated for 
potential errors in their derivation (Weisbrod et al. 2009).  
Table 3. Benchmark values for bioaccumulation metrics that are relevant for non-aquatic organisms (Modified 
from: Weisbrod et al. 2009). BSAF = Biota Soil/Sediment Accumulation Factor. BMF = BioMagnification Factor. 
TMF = Trophic Magnification Factor. OC = Organic carbon. LC = Lipid Content. 
Bioaccumulation metrics Measurement 
unit 
Benchmark 
values 
Laboratory Invertebrates BSAF Kgsoiloc/Kgbiotalc 3 
Mammal BMF Kgprey/Kgmammal 100 
Avian BMF Kgprey/Kgavian 10 
TMF - 10 
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In order to overcome the limitations of the current legislative schemes on bioaccumulation 
assessment, Gobas et al. (2009) propose a scientific definition for 'bioaccumulative substances' and a 
tiered framework outlining how various metrics can be used for identifying 'bioaccumulative' 
substances. According to the Authors, 'A substance is considered bioaccumulative if it biomagnifies in 
food chains. Biomagnification is defined as the phenomenon wherein the normalised concentration 
(or fugacity) of the chemical in biological organisms increases with increasing trophic position' (Gobas 
et al. 2009). Based on this definition, various criteria using different types of information (e.g. field 
studies, laboratory tests, food web modelling, QSARs) are discussed and included in a tiered 
framework structured into five steps representing decreasing availability of experimental data. 
According to Gobas et al. (2009), the selection of an appropriate food web and the use of more 
comprehensive parameters such as the Trophic Magnification Factor (TMF) and the Biomagnification 
Factor (BMF) for both aquatic and non-aquatic food chains would ensure that bioaccumulation in 
non-aquatic organisms is also assessed. Consequently, Step 1 of the framework involves the selection 
of appropriate food webs that should include both water- and air-respiring organisms and, 
specifically, upper trophic level organisms such as raptors, whales and humans. Step 2 asks for 
characterisation of the TMF, which represents the most conclusive evidence of the ability of a 
substance to biomagnify in food webs (Gobas et al. 2009; Conder et al. 2012). A TMF > 1 is therefore 
the proposed criterion to 'confirm' that a substance is bioaccumulative (Gobas et al. 2009). If the 
TMF cannot be calculated because of lack of relevant field studies, the BMF should be used (Step 3). 
The BMF is less comprehensive since it focuses on one trophic relationship. Consequently, a BMF > 1 
is used to identify a 'probable' bioaccumulative substance. Rainbow trout and rats are considered as 
suitable species for a BMF test (Gobas et al. 2009). In Step 4 available BCF or BAF values are used to 
determine whether a substance can biomagnify in water-respiring organisms of aquatic food webs. In 
this case, a BCF and/or BAF value higher than 5000 L/Kg indicates a 'possible' bioaccumulative 
substance. A standard protocol on how to perform a bioconcentration study with fish exists (OECD 
TG 305: OECD 2012). This protocol has been recently updated to consider dietary exposure in 
addition to aqueous exposure when testing bioaccumulation in fish. A standard protocol on how to 
test bioaccumulation in soil organisms (i.e. earthworms) (OECD 2010) and sediment-dwelling 
organisms (OECD 2008) is also available. Step 5 is applied when experimental/empirical data to 
assess bioaccumulation potential are not available and is based on the evaluation of physico-
chemical properties of the substance (e.g. Kow and Koa) as well as the application of predictive models 
as suggested e.g. by Nichols et al. (2009). Criteria used in Step 5 can only indicate a 'potential' 
bioaccumulative substance. 
It has to be pointed out that the definition of 'bioaccumulative' substance as proposed by Gobas et 
al. (2009) has some limitation as it only considers substances that biomagnify in food chains as 
bioaccumulative. According to the tiered framework, a substance that does not exhibit 
biomagnification properties, i.e. TMF or BMF < 1, is not considered as bioaccumulative. However, 
lack of biomagnification along the food chain or at some trophic levels does not necessarily mean 
that a substance fails to meet criteria for bioaccumulation based on BAF/BCF values (ECHA 2012a). 
Consequently, the proposed criteria and tiered framework tend to neglect the case of a substance 
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that exhibits bioaccumulation properties in lower trophic levels due to e.g. bioconcentration 
processes but undergo trophic dilution along the food chain. Moreover, a substance may or may not 
exhibit biomagnification properties based on the specific trophic level and species that is investigated 
when a BMF or TMF is determined. To this end, it is recommended that multiple trophic levels are 
represented in the data set used to assess biomagnification, and not just a single ratio 
(Swackhamer et al. 2009). For the same reason, extrapolation of biomagnification data from aquatic 
to terrestrial food webs and vice versa cannot be justified (Swackhamer et al. 2009).  
There could also be the case when an increase in contaminant concentration up to a food chain is 
detected (i.e. TMF > 1) but the concentration levels in the analysed organisms are not sufficient to 
cause adverse effects. In this context, an analysis of the toxicological significance of tissue residues 
via calculation of hazard quotients may be helpful (e.g. as suggested by Weisbrod et al. (2009)). 
Another point to be raised is that the tiered framework according to Gobas et al. (2009) focuses on 
the use of field metrics as the most conclusive criteria for bioaccumulation assessment, which are 
expensive and time-consuming and may not be the most suitable and pragmatic metrics for a 
screening approach. To this end, the Authors suggest that for screening large number of substances 
the framework is used in reverse order. This means starting from an initial phase (Step 5) where 
substances are prioritised based on their physico-chemical properties and results from food web 
bioaccumulation models up to the use of empirically determining BMF and TMF values (Step 1) for a 
reduced sub-set of compounds that need in-depth investigation before drawing a conclusion on their 
bioaccumulation potential. 
In November 2009, the international Lab-Field Bioaccumulation Workshop sponsored by the 
International Life Sciences Institute Health and Environmental Sciences Institute (ILSI HESI), the US 
Environmental Protection Agency, and SETAC was held in New Orleans, Louisiana (USA). The 
workshop aimed at: i) comparing laboratory and field measurements of bioaccumulation endpoints; 
ii) evaluating the reasons why laboratory and field bioaccumulation data may not align; and iii) 
exploring the measurement and application of TMFs (Burkhard et al. 2012a). The results of the 
workshop are summarised in a series of five articles. 
An important outcome of the workshop is a clear distinction between the terms 'bioaccumulation' 
and 'biomagnification'. Burkhard et al. (2012b) clarified that 'bioaccumulation' causes increased 
chemical concentrations in an organism compared to its ambient environment through all exposure 
routes and 'biomagnification' only quantifies increases between an organism and its prey due to 
dietary absorption.  
As food is the main contributor to the uptake of hydrophobic contaminants for benthic, pelagic and 
terrestrial organisms (Selck et al. 2012), and dietary exposure seems to be the driver of accumulation 
at higher trophic levels such as birds, marine mammals, and humans (Conder et al. 2012), the 
workshop participants concluded that all available data and metrics (not only BCF and/or Kow) 
should be used in a weight of evidence approach to assess bioaccumulation potential of chemicals 
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in a regulatory context (Borgå et al. 2012; Burkhard et al. 2012b; Conder et al. 2012; Selck et al. 
2012). To this end, Burkhard et al. (2012b) propose the use of fugacity ratio as a common 
dimensionless standard metric for integration of data about different species and food webs, 
including non-aquatic ones, and comparison of results from laboratory and field data. The 
conversion to a fugacity ratio would also overcome the issue of defining scientifically sound cut-off 
values for each metric (Burkhard et al. 2012b). However, this approach is not universally applicable 
and cannot be used for e.g. ionic organic chemicals such as PFOS. Moreover, this approach only 
detects chemicals that biomagnify (Burkhard et al. 2012b). Though as explained by the Authors, 
fugacity ratios higher than 1 indicate biomagnification and chemicals that biomagnify do 
bioaccumulate; however, fugacity ratios lower than 1 indicate lack of biomagnification but chemicals 
may still bioaccumulate to unacceptable concentrations at lower trophic levels and additional 
evidence may be needed to derive a conclusion.  
The framework proposed by Gobas et al. (2009) was also discussed at the workshop mentioned 
above, and TMF was acknowledged as the most conclusive metric to assess biomagnification in food 
webs (Borgå et al. 2012; Burkhard et al. 2012b; Conder et al. 2012). However, Borgå et al. (2012) 
along with Conder et al. (2012) critically analysed the application of TMF for regulatory screening and 
assessment of bioaccumulation potential. First, both TMF and BMF measure biomagnification 
through trophic transfer, which is one aspect of the bioaccumulation process according to the 
definitions agreed on at the workshop (Conder et al. 2012). In addition, it is important to consider 
that TMF values can only be calculated for chemicals that have been in commerce long enough to 
be released, detected and quantified in environmental samples (Borgå et al. 2012), and hence not 
applicable to e.g. emerging contaminants or for a pro-active evaluation of new substances to be 
placed on the market. To this end, it is also necessary that appropriate analytical techniques are 
available (Borgå et al. 2012), which may not always be the case. Moreover, a TMF implies sampling 
efforts and sacrifice of animals, which is in contrast with the reduction of animal use as promoted by 
REACH (Conder et al. 2012). Consequently, TMF may not be the most suitable metric for screening 
purposes. Another consideration is that the TMF is an 'estimation' of biomagnification in the food 
web that is investigated in the study as the true value and it can also be determined if all organisms 
and trophic levels are considered (Conder et al. 2012). It is therefore recommended that the TMF 
value is used for regulatory purposes only if accompanied by the statistical analysis of its variability 
and a statistical power analysis of the study performed (Conder et al. 2012). An aspect to be taken 
into account when using TMF is the relevance of the food web, especially when conclusions from 
multiple studies are available. It is indeed acknowledged by both studies performed, i.e. by Borgå et 
al. (2012) as well as by Conder et al. (2012), that TMF values are influenced by various biological 
factors such as: i) different metabolic rates between poikilotherms and homeotherms that lead to 
higher TMF values in food webs including homeotherms, especially if they are apex predators; ii) 
different biotransformation abilities that lead to e.g. higher TMF values in food webs including avian 
or mammals predators; iii) uptake across respiratory surfaces that affect accumulation at low trophic 
levels; iv) size and age in fish; and v) sex in mammals. Consequently, biomagnification of a chemical 
in terrestrial ecosystems can be much higher than in some aquatic food webs (Borgå et al. 2012). 
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Taking into account the paucity of TMF data in terrestrial ecosystems Borgå et al. (2012) suggest that 
TMF values for food webs containing water-respiring organisms only are evaluated separately from 
the ones containing air-breathing organisms. Burkhard et al. (2012b) also point out that TMF reflects 
an average change between trophic levels in food chains and is therefore less variable than BMF. 
However, in some cases TMF may obscure biomagnification relationships between individual trophic 
levels of particular interest (Conder et al. 2012). Therefore, it is suggested that BMF values are also 
considered when biomagnification potential is evaluated (Conder et al. 2012). Finally, TMF does not 
take into account the initial transfer of chemicals from environmental compartments such as water, 
sediment and soil into organisms while BCF or BAF do, which can indicate bioaccumulation even 
when TMF values are lower than 1 (Conder et al. 2012). Accordingly, Conder et al. (2012) conclude 
that TMF is the most accurate biomagnification metric and should be incorporated into the 
regulatory framework. Based on the above considerations, field-based TMF cannot be used for 
screening purposes but should be considered in a step-by-step process in cases when the available 
information suggests bioaccumulation and more information is needed on biomagnification 
potential at higher trophic levels (including humans). Supporting lines of evidence could be BMF 
(to evaluate individual relationships between trophic levels) and BCF/BSAF/BAF (to estimate initial 
transfer from abiotic compartments into biota). Conder et al. (2012) also evaluated the applicability 
of other metrics (i.e. BMFTL18, BSAFTL, BAFTL, BCF, laboratory BAF, food web bioaccumulation models, 
Kow, and Koa) as alternatives when the TMF cannot be applied or is not available, and suggest that 
none of the metrics is applied individually but all contribute as multiple lines of evidence to a more 
comprehensive and holistic assessment of the biomagnification potential.  
In conclusion, the regulatory use of TMF is recommended by several Authors but research efforts on 
improving the scientific understanding and defining measurement methods are needed (Bukhard et 
al. 2013). In order to overcome the limitation of field-based TMF, which can be measured only when 
the substance is already on the market and released into the environment, and of laboratory-based 
TMF, which are complex, expensive and time consuming, Solomon et al. (2013) have recently 
emphasised the use of model-based TMF (i.e. TMF values estimated by food web models) for 
screening of biomagnification potential of substances. 
Concerning non-aquatic food webs, Muller et al. (2011) point out that the selection of the species to 
be used to calculate trophic levels and of the appropriate trophic enrichment factor need further 
study. Moreover, standard operating procedures as well as guidance on how to use TMF in 
combination with other laboratory and field metrics (e.g. BCF, BAF, BSAF, BMF) in a weight of 
evidence approach are fundamental (Bukhard et al. 2013). 
It is worth to notice that Jonker (2011) questions the meaningfulness of TMF and BMF as their 
variation could merely reflect different affinity of chemicals for different lipid compositions across 
                                                            
18 TL = Trophic Level-normalised. 
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species, and therefore may not be related to their hydrophobicity or bioaccumulation potential. In 
this case, species-specific BAF may result more valuable in risk assessment (Jonker 2011).  
More recently, Goss et al. (2013) have suggested the elimination half-life of a chemical (EL0.5: the 
time at which the 50% of a chemical is eliminated by an organism) as an alternative metric to the 
regulatory BCF as well as to the BMF and TMF. The Authors argue that BMF and TMF only reflect 
exposure through diet, depend largely on biological and ecological factors rather than chemical's 
properties, are difficult to normalise and standardise, and are not applicable to new chemicals and 
consequently not suitable for hazard screening. On the contrary, EL0.5 accounts for all exposure 
routes, is directly linked to the physico-chemical properties of substances, reflects susceptibility of 
chemicals to undergo biotransformation, can be applied to both water-respiring and air-breathing 
organisms, is less variable than BMF and TMF values and is practical as usually measured in 
bioaccumulation and bioconcentration tests (Goss et al. 2013). It therefore represents an appropriate 
metric for bioaccumulation screening in a tiered approach. The Authors demonstrate that EL0.5 can 
be linked to BMF and proposes a mathematic procedure to derive a threshold level for EL0.5 that is 
equivalent to BMF equal to 1. Specifically, the Authors propose an EL0.5 value of 70 d as criterion that 
keep the BMF smaller than 1 under physiological conditions that are realistic and representative 
for humans. The Authors suggest that a tiered approach is used for bioaccumulation assessment. In 
Tier 1 biotransformation is neglected and chemicals that are screened out are those whose physico-
chemical properties allow exhalation and urination to efficiently compensate for the intake. 
According to Goss et al. (2013), EL0.5 < 70 d correspond to log Kow < 1.3 and log Koa < 4.5 in air-
breathing organisms, which are criteria similar to the ones proposed by Kelly, Gobas et al. but more 
stringent than the ones used under REACH. For water-respiring organisms, this leads to log Kow < 6, 
which is a less stringent than the value used under REACH (Goss et al. 2013). This highlights the 
importance of assessing bioaccumulation in aquatic and non-aquatic organisms separately, even if 
the metric is the same (Goss et al. 2013). It is also underlined that although EL0.5 can be in principle 
applied to inorganic compounds, the scientific understanding on their behaviour is currently so 
limited that it would not be feasible (Goss et al. 2013). In Tier 2, biotransformation is taken into 
account for those chemicals that are not screened out in Tier 1. The biotransformation rate constant 
may be estimated in silico and/or in vitro. In this tier, the occurrence of metabolites that may be of 
regulatory concern needs also to be addressed (Goss et al. 2013). Chemicals that are not screened 
out in Tier 1 and 2 are tested in vivo in Tier 3. Goss et al. (2013) recommend that the EL0.5 is 
measured for various reference animals in standardised tests, which may be more problematic for 
non-aquatic organisms. 
In February 2011, an international workshop on 'Moving Bioaccumulation Assessments to the Next 
Level: Progress Made and Challenges Ahead' was organised by the ILSI Health and Environmental 
Sciences Institute. According to the workshop summary report available online (ILSI HESI 2011), 
participants agreed that bioaccumulation in non-aquatic organisms and food chains is a major 
research interest and recommended that: i) existing bioaccumulation models are expanded to 
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include non-aquatic organisms; ii) a consensus terrestrial food web bioaccumulation model is 
developed; and iii) the metabolism rate in non-aquatic species is further investigated.  
As a follow-up, a specific workshop on 'Terrestrial Bioaccumulation' was organised by the ILSI Health 
and Environmental Sciences Institute in January 2013. The outcomes of the workshop were 
presented in a dedicated session at the SETAC North America 34th Annual Meeting in Nashville on the 
17th -21st November 2013. In summary, Biota-Soil Accumulation Factors (BSAF) and BMF are 
confirmed to be robust metrics for evaluating the bioaccumulation potential in non-aquatic food 
webs (Conder et al. 2013). However, several aspects still need further investigation and optimisation 
including: i) the selection of target terrestrial species; ii) spatial and temporal issues; iii) non-lethal 
sampling; iv) statistical analysis that accounts for variation in BSAF and BMF estimates from field 
data; iv) mesocosm studies to bridge the gap between laboratory and field data (Conder et al. 2013; 
Arblaster et al. 2013). Concerning the BMF, predatory birds seem to exhibit higher statistical 
robustness and may therefore provide more definitive assessments of the biomagnification 
potential, if studies and analytical approaches will be optimised (Arblaster et al. 2013).  
5.3 Human-specific criteria 
Since humans are air-respiring organisms and top predators in both aquatic and terrestrial food 
chains, regulatory bioaccumulation criteria based on aquatic species, or referring to a specific 
medium, may not be appropriate for humans as we consume food of different origins (Czub and 
McLachlan 2004b). Moreover, biomagnification of a compound does not necessarily lead to exposure 
to humans: although it is reasonable to assume that humans are significantly exposed to persistent, 
hydrophobic organic chemicals via e.g. fish consumption, some compounds may bioaccumulate in 
lower trophic levels but be metabolised by mammalian enzyme systems or accumulate in food webs 
by different mechanisms (Swackhamer et al. 2009). 
According to McLachlan et al. (2011), the criteria suggested in Section 5.1 and 5.2 (e.g. Koa, BMF, 
TMF) may be of limited value for humans because bioaccumulation is still assessed in isolation, 
without considering it as a part of the whole environment. To this end, the Authors support the use 
of an integrative multimedia approach to assess bioaccumulation in humans that takes into 
account partitioning properties, biotransformation and multimedia exposure (Czub and McLachlan 
2004b; McLachlan et al. 2011). Specifically, Czub and Lachlan (2004b) linked a human 
bioaccumulation model for POPs (i.e. ACC-HUMAN; Czub and Lachlan 2004a) to a multimedia model 
and calculated a new parameter named Environmental Bioaccumulation Potential (EBAP). EBAP is 
defined as the ratio between the quantity of the body burden of a certain chemical in a human 
organism and the quantity of the chemical in the whole environment (m2/organism). The Authors 
suggest that the EBAP could support a comparative risk assessment and the 
identification/prioritisation of potentially bioaccumulative substances in humans. The results from 
this study show that only chemicals with log Koa greater than 6 (i.e. less volatile compounds that are 
inefficiently eliminated via exhalation) can accumulate in humans regardless the nature of their diet 
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(aquatic rather than agricultural). When the agricultural diet only is taken into account, chemicals 
with log Kow in the range 2-9 and log Koa in the range 6-10 are found to be potentially bioaccumulative 
in humans. These results show discrepancies with the log Kow-based method: while log Kow identifies 
hydrophobic but relatively low volatile substances (i.e. log Kow > 5 and log Koa < 6) as bioaccumulative, 
the EBAP shows that in humans they can be eliminated via respiration; while log Kow does not 
consider less hydrophobic and non-volatile substances (i.e. log Kow 2-5 and log Koa > 5) as 
bioaccumulative, EBAP predicts them as bioaccumulative through the agricultural food web.  
Similarly, in another study Czub et al. (2008) linked the zonally averaged global transport model 
Globo-POP with the Arctic version of ACC-HUMAN to calculate the Arctic Contamination-
Bioaccumulation Potential (AC-BAP) for the Inuit indigenous sub-population through a marine diet. 
This parameter is defined as the ration between human body burden of the chemical and the 
quantity of chemical cumulatively emitted to the global environment (Czub et al. 2008). The study 
shows that persistent chemicals characterised by log Kow in the range 3.5 and 8.5 and log Koa higher 
than 6 obtained AC-BAP values of at least 10% of the maximum value (Czub et al. 2008).  
Another finding pointed out by Czub and Lachlan (2004b) is that EBAP values were nearly constant 
over a large spectrum of partitioning properties of organic contaminants, thus indicating that 
partitioning properties are not the primary determinants of bioaccumulation in humans.  
In a more recent study, Mc Lachlan et al. (2011) have shown that biotransformation is a more 
significant determinant of bioaccumulation in humans and substances with similar partitioning 
properties may have a different bioaccumulation potential because of matabolisation and/or 
excretion. The Authors calculated a new parameter named multimedia Bioaccumulation Factor 
(mmBAF) (m2/organism), which is equivalent to EBAP but covers non-persistent chemicals in 
addition to persistent ones. According to Mc Lachlan et al. (2011), mmBAF values also show to 
slightly vary over a large spectrum of partitioning properties but turn out to vary by 9 orders of 
magnitude over a large spectrum of biotransformation constants.  
A recent development has also been the implementation of the poly-parameter Linear Free Energy 
Relationship (pp-LFER) in the ACC-HUMAN human bioaccumulation model (Undeman et al. 2011). 
This approach tried to overcome the traditional modelling paradigm based on a single linear 
relationship between the lipid-water partitioning and the octanol-water partitioning by considering 
all possible intermolecular interactions due to different human tissues (fat, muscle, blood, skin, liver, 
brain and lungs). However, the implementation of pp-LFER showed little benefit in terms of results 
and uncertainties.  
A Physiologically Based Toxicokinetic model for screening of human bioaccumulative substances was 
developed by Tonnelier et al. (2011). The model confirms the weak influence of log Kow on human 
BCF values, as already demonstrated by Czub and Mc Lachlan (2004a; 2004b) and McLachlan et al. 
(2011), and shows a strong discrepancy between BCF values for fish and humans. This also suggests 
that new criteria should be investigated and used for bioaccumulation assessment in humans. The 
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Authors propose an approach describing the bioaccumulation potential as a function of hepatic 
clearance and renal excretion. Both parameters can easily be obtained through in vitro testing 
(Tonnelier et al. 2011) although test guidelines would be needed to ensure application in a regulatory 
context. The hepatic clearance appears to be the main driving factor in the study of concern 
(Tonnelier et al. 2011). 
In line with the abovementioned, that means elimination and biotransformation as key determining 
parameters of bioaccumulation in humans, Goss et al. (2013) propose that the whole body total 
elimination half-life (HLT) and whole body biotransformation half-life (HLB) are considered as 
metrics for bioaccumulation assessment. To this end, Arnot et al. (2014) have recently developed 
and validated screening-level QSARs for estimation of in vivo HLT and HLB for organic chemicals in 
humans. 
Table 4. Criteria and related threshold values for screening and assessment of 
bioaccumulation/biomagnification potential in non-aquatic organisms (including humans) as proposed in the 
scientific literature. 
Criteria Threshold value Description Reference 
Log Koa > 5 & Log 
Kow > 2 (no 
'hydrophobicity 
cut-off') 
Identification of non-metabolised 
hydrophobic organic substances that have 
the potential to biomagnify in non-aquatic 
food chains (humans excluded) 
Kelly and Gobas 
2003; Gobas et 
al. 2003 
Log Koa > 6 & Log 
Kow: 2-10 
Identification of non-metabolised 
hydrophobic organic substances that have 
the potential to biomagnify in non-aquatic 
food chains and air-breathing organisms of 
aquatic food-chains (humans excluded) 
Kelly et al. 2007 
Log Koa > 6 & Log 
Kow > 2 (no 
'hydrophobicity 
cut-off') 
Identification of non-metabolised 
hydrophobic organic substances that have 
the potential to biomagnify in humans 
Kelly et al. 2007 
Log Koa > 5 & Log 
Kow: 2-12 
Identification of non-metabolised 
hydrophobic organic substances that have 
the potential to biomagnify in non-aquatic 
food chains (humans excluded) 
Armitage and 
Gobas 2007 
Octanol-air partitioning 
coefficient (Koa) & octanol-water 
partitioning coefficient (Kow) 
 
 
Log Kow > 1.3 & 
Log Koa > 4.5 
Identification of non-metabolised substances 
that have the potential to biomagnify in air-
breathing organisms 
Goss et al. 2013 
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Table 4. (cont.) 
Criteria Threshold value Description Reference 
 Log Kow 2-9 & Log 
Koa > 6 
 
 
Log Kow 2-9 & Log 
Koa 6-10 
Identification of substances that have the 
potential to biomagnify in humans regardless 
the nature of their diet (aquatic or 
agricultural) 
Identification of substances that have the 
potential to biomagnify in humans if 
agricultural diet is considered 
Czub and Lachlan 
2004a; b 
Biota-Soil Accumulation Factor 
(BSAF) in soil earthworms 
BSAF > 1  Indication that a substance can 
bioaccumulate from soil into organisms at 
the base of the non-aquatic food chain 
(uptake via dermal contact with soil pore 
water and soil particles ingestion).  
Weisbrod et al. 
2009; OECD 
2010; ECHA 
2012b; Conder et 
al. 2013 
Bioconcentration Factor (BCF) in 
soil earthworms  
- Indication that a substance can 
bioaccumulate from soil into organisms at 
the base of the non-aquatic food chain 
(uptake via dermal contact with soil pore 
water) 
Jager 1998; ECHA 
2012b; c 
Bioconcentratio Factor (BCF) in 
sediment-dwelling earthworms  
- Indication that a substance can 
bioaccumulate from soil into organisms at 
the base of the non-aquatic food chain 
(uptake via dermal contact with sediment 
pore water) 
ECHA 2012b 
Bioaccumulation Factor (BAF) in 
soil earthworms (laboratory-
based) 
- Indication that a substance can 
bioaccumulate from the surrounding 
environment into the considered organism 
(steady-state conditions, all uptake routes 
including the diet) 
OECD 2010 
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Table 4. (cont.) 
Criteria Threshold value Description Reference 
Biomagnification Factor (BMF) in 
non-aquatic organisms  
 
 
 
 
 
BMF > 1 
 
BMF < 1 
 
 
 
 
 
 
 
Indication that a substance can biomagnify in 
the considered trophic relationship 
Indication that a substance can undergo 
trophic dilution in the considered trophic 
relationship 
o Suitable species: rats 
o More statistically robust results for: 
predatory birds 
o Multiple trophic relationships to be 
considered 
Weisbrod et al. 
2009; Gobas et 
al. 2009; Conder 
et al. 2013; 
Swackhamer et 
al. 2009 
 
Gobas et al. 2009
Arblaster et al. 
2013 
Swackhamer et 
al. 2009 
Trophic Magnification Factor 
(TMF) in non-aquatic food chains 
 
 
 
  
TMF > 1 
 
TMF < 1 
Indication that a substance can biomagnify 
along the considered non-aquatic food chain 
Indication that a substance can undergo 
trophic dilution along the considered non-
aquatic food chain 
 
 
o Upper trophic level organisms such as 
raptors, mammals and humans to be 
included 
o Accompanied by the statistical analysis of 
its variability and a statistical power 
analysis of the study performed 
Weisbrod et al. 
2009; Gobas et 
al. 2009; Borga et 
al. 2011; 
Burkhard et al. 
2011b; Conder et 
al. 2011; 
Solomon et al. 
2013 
Gobas et al. 2009
 
Conder et al. 
2011 
Elimination half-life (EL0.5) in 
non-aquatic organisms (in vivo) 
EL0.5 > 70 d 
 
 
 
 
EL0.5 ≤ 70 d 
Indication that exhalation and urination and 
biotransformation cannot compensate for 
the intake and the substance has the 
potential to biomagnify in non-aquatic food 
chains 
Indication that exhalation and urination (and, 
biotransformation, if determined) can easily 
compensate for the intake and the substance 
does not have the potential to biomagnify in 
non-aquatic food chains 
Goss et al. 2013 
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Table 4. (cont.) 
Criteria Threshold value Description Reference 
Environmental Bioaccumulation 
Potential (EBAP) (predicted) 
- Identification of persistent substances that 
have the potential to bioaccumulate in 
humans taking into account partitioning 
properties, biotransformation and 
multimedia exposure (both aquatic and 
agricultural diet) 
Czub and Lachlan 
2004a; b 
Arctic Contamination-
Bioaccumulation Potential (AC-
BAP) (predicted) 
- Identification of substances that have the 
potential to bioaccumulate in Arctic 
indigenous populations taking into account 
partitioning properties, biotransformation 
and multimedia exposure (marine diet) 
Czub et al. 2008 
Bioaccumulation Factor 
(mmBAF) (predicted) 
- Identification of persistent and non-
persistent substances that have the potential 
to bioaccumulate in humans taking into 
account partitioning properties, 
biotransformation and multimedia exposure 
(both aquatic and agricultural diet) 
Mc Lachlan et al. 
2011 
Hepatic clearance and renal 
excretion (in vitro) 
- Identification of substances that have the 
potential to bioaccumulate in humans 
Tonnelier et al. 
2011 
Whole body total elimination 
half-life (HLT) and whole body 
biotransformation half-life (HLB) 
(in vivo or predicted by QSAR) 
- Identification of substances that have the 
potential to bioaccumulate in humans 
Goss et al. 2013; 
Arnot et al. 2014 
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6 Ongoing and future initiatives 
An OECD project named 'Harmonisation of OECD Environmental Assessment Practices for Pesticides 
with Persistent, Bioaccumulative, Toxic and Long-Range Transport (PBT/LRT) Characteristics', chaired 
by the US Environmental Protection Agency (EPA), is currently ongoing. Project goals are: i) to 
facilitate a common understanding of the unique issues for environmental assessment of pesticides 
with PBT/LRT characteristics; ii) to develop a set of definitions of key concepts; and iii) to harmonise 
both empirical and model-based methods (Brady 2011). Assessing bioaccumulation in terrestrial 
ecosystems is one of the issues identified by OECD (Brady 2011). The project's working group will 
consider two country-specific guidance documents, which are under development, as basis for 
harmonisation. The first document is the US EPA PBT/LRT pesticides risk assessment guidance, which 
builds on the US EPA PBT White Paper (US EPA 2008). US EPA is currently evaluating several 
terrestrial bioaccumulation models and using the Koa criteria as a 'flag' of potential terrestrial 
bioaccumulation for those pesticides that are characterised by negligible biotransformation rates 
(Keith Sappington personal communication 31 January 2012). The validation of an earthworm 
fugacity model is also among the US EPA tasks. The second document is the German UBA internal 
guidance on hazard assessment of PBT/LRT substances, including pesticides, biocides, industrial 
chemicals, pharmaceuticals, etc. Currently, the working group is drafting a series of white papers on 
the subject, which will prepare the ground for the OECD harmonised guidance (Keith Sappington 
personal communication 04 September 2013).  
The ECHA Guidance on information requirements and chemical safety assessment. Chapter R.11: PBT 
assessment (ECHA 2012a) is currently under review in order to align it with the REACH Annex XIII 
criteria published in 2011. The consultation procedure is still ongoing and draft versions of the 
updated Guidance Document are downloadable from the ECHA website19. Publication is expected 
soon. The ECHA PBT Expert Group has also selected a list of issues with relevance for the PBT/vPvB 
assessment of substances under REACH, which require further investigation. Among them, terrestrial 
bioaccumulation is one of the priorities in terms of development of screening triggers as well as 
testing and assessment strategies (Peltola-Thies et al. 2014).  
 
                                                            
19 http://echa.europa.eu/support/guidance/consultation-procedure/ongoing-reach  
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7 Conclusions 
It has been demonstrated through experimental and modelling studies published in peer-reviewed 
literature that persistent but low hydrophobic and poorly metabolised organic chemicals can 
biomagnify in non-aquatic food webs and accumulate in human blood and tissues. Since current 
criteria for bioaccumulation assessment in international and European legislative frameworks aimed 
to identify substances with PBT/vPvB properties are mainly based on cut-off values for BCF/BAF 
measured in aquatic species and Kow, there is the risk that these substances are not classified as 
bioaccumulative and consequently not to be properly addressed from a regulatory viewpoint.  
In order to overcome these limitations and fill the gap, several Authors have proposed new metrics 
and models as well as generated data, which could be used and incorporated into the regulatory 
criteria to improve the way the bioaccumulation assessment for the non-aquatic compartment is 
currently performed.  
The literature review points out that there is consensus in the scientific community on the combined 
use of criteria based on predictive physico-chemical parameters such as Koa > 5 or 6 and Kow > 2, 
which are easy to calculate and implement and should therefore be considered within existing 
PBT/vPvB assessment frameworks, especially for screening purposes. However, the impact of 
introducing this in a regulatory context such as e.g. the EU REACH Regulation needs to be evaluated 
more deeply, e.g. via quantification of the additional number of substances that could be identified 
as potentially bioaccumulative due to consideration of the non-aquatic compartment. Moreover, the 
assumption of the 'hydrophobicity cut-off' for substances with log Kow > 9-10 has also been 
questioned in some studies as the examined substances seem to exhibit bioaccumulation potential in 
non-aquatic organisms. It is therefore important that the applicability of the 'hydrophobicity cut-off' 
to non-aquatic bioaccumulation is further investigated and clarified. However, the proposed 
screening approach does not cover those substances that partition into other tissues than lipids, e.g. 
proteins, and is therefore not universally applicable. 
Regarding bioaccumulation in humans, several modelling approaches suggest that biotransformation 
and elimination rather than partitioning properties are the primary determinants. These findings 
could be incorporated in a screening approach through the application of models that take 
biotransformation and elimination processes in humans as well as multi-media exposure into 
account.  
In a more detailed bioaccumulation assessment that is usually performed at higher tier, there is 
general agreement in the scientific community that all available bioaccumulation metrics need to be 
considered as complementary lines of evidence and evaluated in a weight of evidence approach (in 
line with the principles outlined in the REACH Annex XIII published in 2011). Specifically, it is 
recommended that both bioconcentration and biomagnification are investigated by means of 
multiple laboratory and field metrics and that aquatic and non-aquatic compartments are 
separately addressed. The transfer of substances from abiotic compartments to organisms at lower 
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trophic levels, which is mainly driven by bioconcentration processes, could be assessed through 
laboratory metrics such as BCF and BSAF and/or field metrics such as BAF determined with relevant 
soil organisms such as earthworms. Specifically, BSAF and BCF values in earthworms seem to 
represent good indicators for the bioaccumulation potential at the base of non-aquatic food 
chains, despite several technical limitations. As food is the main exposure route for non-aquatic 
organisms and it is demonstrated that biomagnification can be higher in non-aquatic food webs 
compared to aquatic ones, field-based BMF and TMF values determined for non-aquatic food webs 
could be considered. However, further research, e.g. to determine appropriate multiple trophic 
levels and representative species, is necessary before BMF and TMF can be applied in a regulatory 
context. The availability of standardised protocols on how to conduct the experiment is also an issue. 
Therefore, it is recommended in the literature that TMF and BMF values are accompanied by a 
statistical analysis of their variability and a statistical power analysis of the study performed. It is 
also important to take into consideration that field values are costly and time consuming and can 
only be determined for those substances that are on the market / released into the environment 
since a long time. For emerging contaminants or substances that are not yet on the market the 
application of predictive food web models could be considered.  
Finally, the elimination half-life has been recently proposed in the scientific literature as an 
alternative bioaccumulation metric to BCF/BAF/BSAF and BMF/TMF. Such a metric seems to show 
several advantages as it considers all exposure routes, is directly linked to the physico-chemical 
properties of the substance, reflects the susceptibility of the substance to undergo 
biotransformation, is less variable than field metrics, and can be applied to both aquatic and non-
aquatic organisms. However, several aspects of the elimination half-life needs to be further 
investigates, e.g. how to select the representative species of a certain trophic level or food web, and 
how to define the most appropriate threshold values.  
In conclusion, the scientific community has suggested several metrics to overcome the lack of 
consideration of the non-aquatic compartment in the regulatory PBT/vPvB assessment of substances. 
However, research efforts are still needed to improve the scientific understanding of the proposed 
metrics and their cut-off values. Moreover, the impact that the introduction of non-aquatic criteria 
in a regulatory context may have needs to be analysed in depth. 
It is important to note that suggestions provided in this document should not be considered as an 
attempt to define a regulatory strategy on how to screen and/or assess substances based on their 
bioaccumulation potential in non-aquatic organisms nor to evaluate the impact of such a strategy on 
e.g. the REACH implementation process. Further elaboration is needed to integrate the knowledge 
summarised in the present document into the current regulatory framework. This could be the 
work for a dedicated expert group. 
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9 Annexes 
9.1 Annex I - Glossary 
Note: this list explains expressions used in this report, some of them are common in scientific 
literature, but not necessarily defined in legal texts.  
Non-aquatic organisms 
This term refers to all organisms that occur and live in terrestrial environments and are air-breathing, 
including top predators and humans. In the context of this report, the expression 'non-aquatic 
organisms' is preferred to other terms used in the literature, such as 'terrestrial organisms', 'soil 
organisms' and 'air-breathing organisms', as it more clearly encompasses humans as part of the food 
web. 
Persistent Bioaccumulative Toxic/very Persistent very Bioaccumulative (PBT/vPvB) 
PBT substances are substances that are persistent, bioaccumulative and toxic while vPvB substances 
are characterised by high persistence and high tendency to bioaccumulate but not necessarily proven 
toxicity (ECHA 2012a). Because of their very low degradability, PBT/vPvB substances tend to remain 
in the environment for a long time and may accumulate and magnify in organisms' tissues including 
top predators and humans. The accumulation of PBT/vPvB substances is difficult to reverse as the 
reduction or cessation of release into the environment will not necessarily result in a decrease in the 
concentration level (ECHA 2012a). Moreover, the effects of such an accumulation over extended 
periods are not possible to predict though laboratory testing (ECHA 2012a). 
Bioconcentration 
Bioconcentration is the increase in concentration of a substance in or on an organism (or specified 
tissue) relative to the concentration of the substance in the test medium (OECD 2012). For aquatic 
organisms, bioconcentration is the net accumulation of a chemical in an organism that results from 
direct contact with water only, such as through gill membranes or other external surfaces (US EPA 
2003; 2007). Bioconcentration excludes chemical accumulation from other exposure routes and 
sources such as ingestion of organisms and sediment (US EPA 2008). Although not routinely defined 
for terrestrial (air-breathing) organisms, an analogous measure of bioconcentration would be the net 
accumulation of a chemical that results from direct contact with air or soil only, such as through 
respiration or dermal uptake (US EPA 2008). In the OECD Test Guideline 317 (OECD 2010), 
bioconcentration in terrestrial Oligochaetes is defined as the increase in concentration of a substance 
in or on an organism relative to the concentration of the substance in the surrounding medium. The 
increase in concentration is due to the uptake of the substance exclusively from the surrounding 
medium via both the body surface and ingested soil. 
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Bioaccumulation 
Bioaccumulation is the net accumulation of a chemical in an organism from all possible exposure 
routes (respiration, diet, dermal) and sources (water, soil/sediment, air and diet) (Spacie et al. 1995; 
US EPA 2003; 2007). Bioaccumulation results from both bioconcentration and biomagnification 
processes (OECD, 2010). 
Biomagnification 
Biomagnification can be defined as the increase in concentration of a substance in or on an 
organisms (or specified tissue) relative to the concentration of the substance in the food (OECD 
2012). The increase in concentration may occur along a series of predator-prey associations in a food 
web, primarily through the mechanism of dietary accumulation (trophic transfer) (US EPA 2008). 
Steady State 
The steady state is defined as the equilibrium between the uptake and elimination processes that 
occur simultaneously during the exposure phase (OECD 2010). The steady state is reached by a 
system when rates of chemical movement between phases and reactions within phases are constant 
so that concentrations of the chemical in the phases of the system are unchanged over time (US EPA 
2008). A system at steady state is not necessarily at equilibrium; steady-state conditions often exist 
when some or all of the phases of the system have different activities or fugacities for the chemical 
(US EPA 2008). 
Bioconcentration Factor (BCF) [L/Kgww; m3/Kgww; Kgsoilww/Kgww] 
Ratio of the steady state concentration of a substance in an aquatic water-respiring organism (Cb: 
gchemical/Kgww) and the concentration in water (Cw: gchemical/L) determined in a controlled laboratory 
experiment in which the test organisms are exposed to a substance in the water (but not in the diet): 
BCFw = Cb/Cw [L/Kgww] (Gobas et al. 2009). BCF values > 1 indicate that the 
concentration/accumulation in the water-respiring organism is greater than that of the medium from 
which the chemical was measured (US EPA 2008). For terrestrial organisms, an analogous measure of 
a BCF would be the ratio of the concentration of a substance in the organism (Cb) and the 
concentration in air (or soil) (Ca: gchemical/m3; Cs: gchemical/Kgsoilww), in situations where the organism is 
exposed via air or soil only: BCFa = Cb/Ca [m3/Kgww]; BCFs = Cb/Cs [Kgsoilww/Kgww]. 
Biota-Soil/Sediment Accumulation Factor (BSAF) [Kgsoil/sedimentww/Kgbiotaww] 
This parameter measures the bioconcentration of chemicals in sediment/soil dwelling organisms. It 
corresponds to the ratio between the lipid normalised concentration of a substance in the organism 
and the organic content-normalised concentration in the soil/sediment matrix at steady state (OECD 
2010). BSAF is essentially equivalent to BCFlipid/KOC (Weisbord et al. 2009). 
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Bioaccumulation Factor (BAF) [L/Kgww; m3/Kgww; Kgsoilww/Kgww]  
Ratio of the steady state concentration of a substance in an aquatic water-respiring organism (Cb: 
gchemical/Kgww) and the steady state concentration in water (Cw: gchemical/L) determined from field or 
laboratory data in which sampled organisms are exposed to the substance in both the water and 
their diet: BAFw = Cb/Cw [L/Kgww] (Gobas et al. 2009). BAF values > 1 indicate that the 
concentration/accumulation in the organism is greater than that of the medium from which the 
chemical was measured (US EPA 2008). For terrestrial organisms, an analogous measure of a BAF 
would be the ratio of the concentration of a substance in a terrestrial organism (Cb: gchemical/Kgww) to 
its concentration in air (or soil) (Ca: gchemical/m3; Cs: gchemical/Kgsoilww), in situations where both the 
organism and its food are exposed to the substance: BAFa = Cb/Ca [m3/Kgww]; BAFs = Cb/Cs 
[Kgsoilww/Kgww]. 
Biomagnification Factor - laboratory based (BMF) [Kgdietw/Kgww] 
In general, this factor represents the concentration of a substance in a predator relative to the 
concentration in the predator's prey or food at steady state (OECD 2012). The laboratory-based BMF 
is the ratio of the steady state concentration of a substance in a water- or air-respiring organism (Cb: 
gchemical/Kgww) and the steady state concentration in the diet of the organism (Cd: gchemical/Kgdw) 
determined in a controlled laboratory experiment in which the test organisms are exposed to the 
substance in the diet (but not in the water or air): BMF = Cb/Cd [Kgdw/Kgww] (Gobas et al. 2009). Since 
the exposure to the aqueous phase is carefully avoided, a BMF value from a laboratory test cannot 
be compared with a BMF value from a field study (in which both water and dietary exposure may be 
combined) (OECD 2012). 
Biomagnification Factor - field based (BMF) [Kgdietww/Kgww] 
In general, this factor represents the concentration of a substance in a predator relative to the 
concentration in the predator's prey or food at steady state (OECD 2012). The field-based BMF is the 
ratio of the steady state concentration of a substance in a water- or air-respiring organism (Cb: 
gchemical/Kgww) and the steady state concentration in the diet of the organism (Cd: gchemical/Kgdietww) 
determined from field data in which sampled organisms are exposed to the substance via air, water, 
and the diet: BMF = Cb/Cd [Kgdietww/Kgww] (Gobas et al. 2009). 
Trophic Magnification Factor (TMF) [unitless] 
The average factor by which the normalized chemical concentration in biota of a food web increases 
per trophic level. The TMF is determined from the slope (m) derived by linear regression of 
logarithmically transformed normalized chemical concentration in biota and trophic position of the 
sampled biota: TMF = 10^m (Gobas et al. 2009). 
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Octanol-water partitioning coefficient (Kow) [unitless] 
Ratio of the chemical concentrations in 1-octanol (Co) and water (Cw) in an octanol–water system that 
has reached a chemical equilibrium: Kow = Co/Cw (OECD 1995; 2004; 2006; Gobas et al. 2009). 
Octanol-air partitioning coefficient (Koa) [unitless] 
Ratio of the chemical concentrations in 1-octanol (Co) and air (Ca) in an octanol–air system that has 
reached a chemical equilibrium: Koa = Co/Ca (Gobas et al. 2009). 
Metabolisation rate constant (km) 
Reaction constant related to the half-life of a compound in an organism (t1/2): km = ln2/t1/2 
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9.2 Annex II - Abbreviations 
AC-BAP   Arctic Contaimination Bioaccumulation Potential 
ADME   Absorption, Distribution, Metabolism, Elimination 
BAF   Bioaccumulation Factor 
BCF   Bioconcentration Factor 
BCPS   bis-4-chlorophenyl sulfone  
BMF   Biomagnification Factor  
BSAF   Biota Soil/Sediment Accumulation Factor 
CEPA   Canadian Environmental Protection Act 
CLP   Classification Labelling Packaging 
CMC   Critical Micelle Concentration 
DDT   Dichlorodiphenyltrichloroethane 
EBAP   Environmental Bioaccumulation Potential 
ECHA   European Chemicals Agency 
EL0.5   Elimination half-life 
EU   European Union 
FABPs   Fatty Acid Binding Proteins  
GHS   Globally Harmonised System 
HCB   Hexachlorobenzene 
HCH   Hexachlorocyclohexane 
HLB   whole body biotransformation half-life 
HLT   whole body total elimination half-life  
ILSI   International Life Sciences Institute  
  
74 
 
 
JRC-IHCP   Joint Research Centre's Institute for Health and Consumer Protection 
Kaw   protein-air partitioning coefficient 
Koa   octanol-air partitioning coefficient 
Kow   octanol-water partitioning coefficient 
Kpw   protein-water partitioning coefficient 
LC   Lipid Content 
NICNAS   National Industrial Chemicals Notification and Assessment Scheme 
OATs   Organic Anion Transporters 
OC   Organic Carbon 
Octa-BDE   C-Octabromodyphenil ether 
OECD   Organisation for Economic Cooperation and Development 
OSPAR   Convention for Protection of the marine Environment of the North-East Atlantic 
p,p'-DDE   p,p'-dichlorodiphenyldichloroethylene 
PBT   Persistent Bioaccumulative Toxic 
PCB   Polychlorinated biphenyl 
PEG   Partner Expert Group 
PFCAs   Perfluorocarboxylates  
PFOS   Perfluoroctane sulfonate 
PFSAs   Perfluorosulfonates 
pKa   Acid dissociation constant 
POP   Persistent Organic Pollutant 
pp-LFER   poly-parameter Linear Free Energy Relationship 
PPP   Plant Protection Product 
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QSAR   Quantitative Structure-Activity Relationship 
REACH   Registration, Evaluation, Authorisation and Restriction of Chemicals 
SETAC   Society of Environmental Toxicology and Chemistry 
SVHC   Substances of Very High Concern 
TCB   Tetrachlorobenzene 
TCPMeOH   Trischlorophenyl methanol 
TG   Test Guideline 
TMF   Trophic Magnification Factor 
TSCA   Toxic Substances Control Act 
UN ECE   United Nations Economic Commission for Europe 
UNEP   United Nations Environment Programme 
US   United States 
US EPA   United States Environmental Protection Agency 
vPvB   very Persistent very Bioaccumulative 
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